WO1997020536A1 - Device for preparing a medicinal solution reconstituted from two components - Google Patents

Device for preparing a medicinal solution reconstituted from two components Download PDF

Info

Publication number
WO1997020536A1
WO1997020536A1 PCT/CH1996/000429 CH9600429W WO9720536A1 WO 1997020536 A1 WO1997020536 A1 WO 1997020536A1 CH 9600429 W CH9600429 W CH 9600429W WO 9720536 A1 WO9720536 A1 WO 9720536A1
Authority
WO
WIPO (PCT)
Prior art keywords
container
cannula
housings
active substance
bottle
Prior art date
Application number
PCT/CH1996/000429
Other languages
French (fr)
Inventor
Gabriel Meyer
Grégoire MEYER
Original Assignee
Gabriel Meyer
Meyer Gregoire
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gabriel Meyer, Meyer Gregoire filed Critical Gabriel Meyer
Priority to AU76172/96A priority Critical patent/AU7617296A/en
Publication of WO1997020536A1 publication Critical patent/WO1997020536A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2089Containers or vials which are to be joined to each other in order to mix their contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096Combination of a vial and a syringe for transferring or mixing their contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1475Inlet or outlet ports
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006Piercing means
    • A61J1/201Piercing means having one piercing end
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006Piercing means
    • A61J1/2013Piercing means having two piercing ends
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006Piercing means
    • A61J1/2017Piercing means having three or more piercing ends
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048Connecting means
    • A61J1/2058Connecting means having multiple connecting ports
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048Connecting means
    • A61J1/2065Connecting means having aligning and guiding means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2068Venting means
    • A61J1/2075Venting means for external venting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2079Filtering means
    • A61J1/2082Filtering means for gas filtration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2079Filtering means
    • A61J1/2086Filtering means for fluid filtration

Definitions

  • the present invention relates to a device for the preparation of a liquid medicinal solution reconstituted from two components, at least one of which is in the liquid state, the two components being initially contained respectively in two independent sterilized containers hermetically closed, l at least one of these components being an active substance and the other component being said component in the active liquid state or neutral diluent, this device comprising at least one element carrying a cannula for bringing the two containers into communication when they are arranged head to tail, mounted on this element, and a conduit arranged to open through a first orifice in said container containing said active substance and to lead, through a second orifice, to a transfer nozzle for said reconstituted liquid medicinal substance
  • the withdrawal of the syringe can cause contaminating projections, unless using a syringe needle of special construction provided with a. vent or a two-way valve with a predetermined opening threshold and, in some cases, a guard or a valve system that opens only when the needle is connected to a vial, to a pocket infusion or similar
  • the needle of the syringe used to carry out the transfer is a hypodermic needle which will have to be changed between the two operations which consist one of reconstituting the solution and the other has to inject this solution according to the prescriptions defined by the rules of hygiene medical
  • the diluent may already be contained in a pre-filled syringe which it is sufficient to connect to the bottle of active substance to effect the reconstitution and the transfer of the mixture into the syringe If the whole mixture is not transferred into the syringe, there is an overpressure in the system, overpressure which will cause contaminating projections during the separation of the syringe and the vial
  • the parenteral medicinal solution reconstituted from the two basic components is in the bottle which initially contained the active substance, from which it can be withdrawn after removal from the transfer set, using a syringe by aspiration, after puncturing the cap. of the vial using the hypodermic needle of this syringe
  • Patent application PCT / CH93 / 00282 describes a two-chamber system which consists of two separate containers, one of which contains the active substance and the other of the diluent.
  • the diluent can be sterilized by heat and then aseptically combined. and tightly sealed to the container containing the active substance.
  • Such a device if it is attractive to the end user, has the disadvantage of being costly for the manufacturer and represents a heavy investment for the pharmaceutical industry.
  • Another way of transferring a solution between two bottles consists in using a double-pointed needle, whether or not equipped with a filter, the bottle having to receive the solution to be transferred being already under vacuum.
  • the system has the following drawbacks.
  • the mixing bottle must be packaged and sealed under vacuum, the vacuum must be maintained over time, which is difficult to guarantee, - the user must first couple the bottle containing the solution to be transferred and then couple the bottle under vacuum, if the user does not respect these sequences, he runs the risk of losing the vacuum and being unable to carry out his mixing; - such a system replaces the transfer set using gravity; when mixing is done, disconnect the double needle and puncture the mixture with a syringe and needle in the conventional way.
  • the device illustrating the closest prior art is described in patent US-2,584,397. It includes a rotating mixer support designed to allow the respective contents of two bottles mounted on this support to be mixed. Transfers from one of the components of its vial to the vial containing the other component and from the mixture to a syringe, are carried out through a sealed circuit
  • the device allows in particular the extemporaneous reconstitution of a medicinal solution and its transfer in a syringe
  • the device characterized in that said cannula is arranged coaxially with respect to the two containers mounted head to tail and has a first end which opens out at the interior of said container containing said diluent substantially near its mouth and a second end which opens into said container containing the active substance at a substantially central point, and in that the interior volume of this container is determined so that it is greater than twice the volume of the reconstituted liquid drug substance Said second end of said cannula is located in a central zone, defined as being the central space of said container containing the active substance, which is never crossed by the surface defining the upper level of the drug substance reconstituted in this container, regardless of the position of the latter
  • At least said second end of the cannula has a beveled opening extending over a determined height, and this height is less than the smallest dimension of the smallest section of said central space
  • At least one of said first and second ends of the cannula comprises a harpoon-shaped retaining member, arranged to lock against the inner face of a cap of a container , after the introduction of the latter in head-to-tail position on the device, this container at least being constituted by a bottle closed by a stopper which can be pierced by said second end of the cannula
  • the device comprises at least one support element defining a retaining and guide housing for at least said container containing the active substance and receiving said second end of the cannula
  • the device comprises a first support element defining a first retaining and guide housing arranged to receive a first container containing said component in the liquid state, and a second support element defining a second retaining and guide housing arranged to receive a second container containing said active substance
  • said first and second containers are bottles having a narrowed neck closed by a stopper made of an elastomeric material
  • said first and second housings respectively comprise a zone of narrowed section defining shoulders, this zone of narrowed section being designed to receive the narrowed neck of the vials at the time of activation of the system composed of the device and of the vials placed in the respective housings, and the shoulders being arranged to serve as support for the bodies of these vials
  • said housings are provided with at least one seal forming a tight and antibacterial barrier between the outer walls of the containers and the inner walls of the housings
  • the device comprises a second end-piece arranged in the axis of the transfer end-piece, in a central element of the body of this device, this second end-piece being connected by respective conduits to said cross-section areas narrowed of said dwellings
  • the second nozzle has a filter forming an antibacterial vent
  • At least one of said housings comprises means for allowing a pre-assembly of one of said containers, these means comprising a stop element preventing accidental activation of the system, an antibacterial bead, an anti- return and a blocking element preventing removal of the container after activation
  • the narrowed section area of the housing intended to receive this container comprises a stop with a ramp intended to break a neck of this bulb to release the liquid it contains
  • the transfer tip can be terminated by a female Luer cone and arranged to allow the connection of a syringe having a male Luer tip.
  • the transfer tip can contain a syringe needle arranged to be connected to a syringe for activation of the system and transfer of the reconstituted solution
  • the housing When the container is a glass ampoule, the housing includes an antibacterial filter arranged to filter the liquid component before its transfer through the cannula into the bottle containing the active substance
  • said transfer nozzle is designed to contain a receptacle constituted by a syringe, an empty cartridge or the like.
  • the nozzle is preferably removable for use in combination with said empty cartridge.
  • At least one of said housings is arranged to receive a flame-sealed bulb
  • FIGS. 1A to 1 H represent a first embodiment of the device according to the invention and the different phases of its use, this embodiment lending itself to the pre-assembly of the bottles
  • FIGS. 2A to 21 represent an alternative embodiment of the device of the invention and phases of use of this construction, this embodiment lending itself to the pre-assembly of the bottles
  • FIG. 3 represents an embodiment in which the bottles are not pre-assembled
  • FIGS. 4A to 4J represent another embodiment comprising a tip with a pre-assembled needle
  • FIGS. 5A to 5H represent a variant according to which one of the bottles is replaced by a glass bulb sealed with flame
  • FIGS. 6A to 6C represent a simplified embodiment in which the means for guiding and retaining the bottles are eliminated
  • FIGS. 7A to 7C represent a variant of the embodiment according to FIGS. 6A to 6C
  • FIGS. 8A to 8C show a variant in which a holding and guiding housing is provided for the bottle containing the active substance
  • FIGS. 9A to 9C represent the relative position of the bottle and of the end of the cannula when the bottle is oriented in various positions
  • FIGS. 10A and 10B represent a variant intended for the pre-assembly of the bottles, the sealing being ensured by an O-ring
  • FIG. 11 shows a variant of the device in which the housings are designed to receive flame-sealed ampoules
  • FIG. 12 shows another variant of the device intended to receive an ampoule and a bottle
  • FIGS. 13, 14 and 15 represent the phases of use of the device of FIG. 12,
  • FIGS. 16A, 16B, 16C, 16D and 16E show a variant of the device according to the invention, in a particular use.
  • Figures 17A, 17B and 17C show a use of a bottle initially prepared by the device according to Figures 16
  • the device 10 for the preparation of a medicinal solution reconstituted from two components mainly consists of a body 11, preferably produced by molding in thermoplastic material comprising a central element 12 and two support elements defining two retaining and guide housings 13 and 14 arranged on either side of said central element, and intended to receive respectively two containers, for example two sterilized bottles 15 and 16 (see FIG.
  • the central element 12 carries a cannula 17 which extends on both sides in the housings 13 and 14 and a conduit 18 which opens into the housing 14 through one of its orifices and into a transfer nozzle 19 through a second orifice L ' transfer tip is for example equipped with a Luer cap 19a
  • the two housings 13 and 14 each have a narrowed section zone 13a, 14a which respectively define with the rest of the walls of these housings a shoulder 13b, 14b, whose role will be described below
  • the central element 12 also comprises, in this embodiment a second endpiece 9, disposed substantially in the extension of the transfer endpiece 19, along the same axis, this endpiece having an antibacterial vent function and being equipped at its end of a suitable filter 8 This vent communicates by two conduits 9a and 9b respectively with the retaining and guide housings 13 and 14 Therefore, the air contained in these housings and which is trapped sounded in the housings, more precisely in the heads of these housings, when the bottles 15 and 16 are pre-assembled
  • FIG. 1C The device of the invention, represented in a preferred embodiment, is illustrated by FIG. 1C in its first phase of use or its storage phase II is intended to be used with two bottles such as those represented in the figure 1 B
  • These bottles 15, 16 are closed by plugs 20, 21 made of elastomer crimped by aluminum capsules 22, 23 which together constitute a hermetic and aseptic barrier.
  • FIG. 1C represents a storage position for a pre-assembled system comprising the device 10 and the two containers 15 and 16
  • the next step represented by FIG. 1 D consists in exerting a push respectively P1 and P2 on the bottoms of the bottles 15 and 16 so that the tips of the cannula 17 perforate the plugs 20 and 21 and that the ends of the cannula penetrate respectively inside the bottles 15 and 16
  • the air contained in the housings 13 and 14 escapes through the conduits 9a and 9b and through the vent filter 8, under the pressure of the bottles which remain sealed thanks to the belts 7 of the housings 13 and 14 during the entire activation phase
  • the system is activated. It will be noted that this activation is carried out when the necks of the bottles are engaged in the zones of narrowed section 13a and 14a of the housings and the walls of the bodies of the bottles. are in abutment against the shoulders 13b and 14b defined above
  • a suction syringe 24 comprising a body 25, a plunger 26, a plunger rod 27 coupled to the plunger 26 and a needle holder tip 28 arranged to be adapted to the transfer nozzle 19, is coupled to the device 10
  • a traction exerted on the piston rod 27 causes a suction which results in a vacuum inside the bottle 16, the suction of the air or gas contained in the bottle 16 is carried out through the conduit 18 Thanks to this depression, the diluent contained in the bottle 15 flows into the bottle 16 through the cannula 17 The solution resulting from the mixture of the two components found in the bottle 16 As soon as all of the diluent has flowed into the bottle 16, the vacuum in the system is balanced through the cannula 17 and the conduit 18
  • the tip of the cannula 17 which is inside the bottle 16 is located above the surface of the solution contained in this bottle after the operation consisting in dissolving the lyophilisate in the diluent, this operation being called phase of reconstitution In addition, this tip occupies a position such that, whatever the position of the bottle, the substantially flat surface which defines the level of the solution always remains below this tip so that the solution can never flow through cannula 17
  • the next step consists in refilling the bottles 15 and 16 which were under vacuum under the action of the vacuum created by the pulling of the piston rod 27 of the syringe 24, by restoring atmospheric pressure in these vials and removing the partial vacuum in the syringe 24 so that it is capable of receiving the reconstituted solution
  • This recovery of atmospheric pressure in the system is done using the syringe 24 which is released ia traction on the piston rod 27 which is sucked up by the vacuum prevailing in the bottles 15 and 16
  • the device To withdraw the solution, as shown in FIG. 1G, or a certain quantity of solution by means of the syringe 24, the device is turned over, so that the bottle 16 is located above the bottle 15
  • the endpiece carries needle 28, and consequently the syringe, is thus in communication with the interior of the bottle 16 via the conduit 18.
  • the solution can be drawn up by syringe 24 which can draw up to the last drop of liquid since the conduit 18 opens into the interior of the vial 15 flush with the stopper 21
  • a slight depression occurs in the two vials which remain in communication
  • no liquid is likely to escape and contaminate the nursing staff, since the liquid residues are sucked back into the bottles where there is a depression
  • This slight depression exists from the moment when the first drops of solution are drawn into the syringe
  • This depression does not can never be important, because it automatically balances in the two vials through the cannula 17 This allows the user to withdraw only a small part of the reconstituted solution by precisely measuring this quantity using the syringe and detach this syringe from the device at any stage of collection without any risk of contamination
  • FIGS. 2A to 21 illustrate an alternative embodiment according to which the device 10 is provided with a pre-assembled needle 30 arranged to ensure the transfer of the reconstituted solution into a transfusion bag 31 or the like.
  • the central element 12 of the device is provided with a relatively long transfer nozzle 19 which consists of a fixed support carrying the needle 30 and a removable tubular part 32 ensuring sealing with the needle 30, initially closed by a Luer cap 33
  • All the other components of the device 10 and in particular the housings 13 and 14 are, apart from a few details of shape, identical to those described previously
  • the bottles 15 and 16 have shapes and functions similar to those described with reference to the figure 1 B, although the plugs 20 and 21 have some constructive differences
  • phase of placing the vials or, in certain cases, the storage phase, represented by FIG. 2C, the activation phase of FIG. 2D, the phase of reconstitution of the drug solution from the two components, represented in FIG. 2E, the pressure balancing phase represented by FIG. 2F, the suction phase represented by FIG. 2G and the phase of separation and neutralization of the system as represented by FIG. 2H, are practically identical to the corresponding phases of figures 1 C to 1 H
  • the transfer phase of the entire mixture or of the balance of this mixture remaining after withdrawal of a certain quantity during the aspiration phase represented by FIG. 2G, into a transfusion bag 31 or the like takes place when the needle 30 is exposed after the removal of the removable tubular part 32
  • the transfer is made by pressurizing the system by applying pressure to the bag which transfers pressurized air into the bottles After releasing this pressure on the pocket, the overpressure prevailing in the system causes the solution to flow into the pocket
  • the reconstitution and the transfer of the solution to the transfusion bag 31 or similar can be done directly by exposing the needle 30 from the start and by connecting this needle to the bag 31 before reconstitution without going through the phases 2E, 2F , 2G and 2H which use an intermediate syringe
  • the mixing is done by putting the system under pressure by exerting a push on the pocket which transfers air into the bottles, the diluent bottle being directed upwards After this pressure is released on the pocket , a vacuum is created in the reconstitution bottle and the diluent flows through the cannula Transfer is done in the same way as above, but taking care to direct the bottle containing the reconstituted solution upwards
  • Construction of the system represented by FIGS. 2A to 21 has the following advantages - the reconstitution and the transfer can be done by means of a syringe in order to withdraw a small part of the reconstituted solution in the syringe, as represented by FIG.
  • FIG. 3 represents an alternative embodiment of the device as shown in FIG. 1A
  • the housings 13 and 14 do not have a belt or beads to form a waterproof antibacterial barrier 11 exists between the walls of the housings and those of the bottles sufficient clearance to allow the air to escape when these bottles are put in place.
  • the nozzle 9 with its vent filter 8 have been eliminated since they are not justified in this case.
  • all the phases of use after the placement of the bottles are identical to those described with reference to FIGS. 1A to 1 H The same parts have the same references as those of FIG. 1A
  • the device 10 comprises, as before, a body 11 with an element central 12 and two support and guide elements 13 and 14 Given that this device is intended for pre-assembly of the two bottles 15 and 16 illustrated in FIG. 4B, the housings 13 and 14 include beads 7 forming both a gasket and an antibacterial barrier between the interior walls of the housings and the exterior walls of the bottles
  • the central element 12 of the device is provided with a relatively long transfer nozzle 19, of substantially cylindrical shape, and which ends in a section d end 40, frustoconical arranged to receive a needle-carrying element 41, for example of the Luer cone type, which effectively carries a needle 42 housed in the transfer nozzle 19
  • the needle-carrying element 41 is closed by a Luer cap 19a identical to those described above.
  • the transfer nozzle 19 has an inner ring 43, preferably made of an elastomeric material, which ensures both centering, holding in position and sealing at the level of this needle, when '' it is housed, as shown precisely in Figure 4A inside the transfer nozzle 19
  • a second nozzle 9 equipped with a vent filter 8 is necessary
  • FIG. 4C represents the device in an initial position, which is preferably its storage position, in which the bottles of FIG. 4B are pre-assembled in the housings 13 and 14
  • FIG. 4D represents the activation phase in which the user has exerted respectively a push P1 on the bottle 15 containing the diluent and a push P2 on the bottle 16 containing the active substance so as to put the two bottles in communication through the cannula 17, the tips of which have respectively punctured the plugs 20 and 21
  • the gas contained in the housings 13, 14 escapes through the conduits 9a and 9b and through the filter 8 under the pressure of the bottles which remain sealed thanks to the belt 7 .
  • FIG. 4F represents the balancing of the pressures in the two bottles which communicate with each other by means of the cannula 17
  • FIG. 4G represents a phase of sampling part of the reconstituted solution
  • part of the mixture is aspirated by means of the syringe, the device having previously been turned over so that the bottle 16 containing the solution reconstructed is found above and that the solution can flow through the conduit 18
  • the end of the cannula 17 is situated substantially in a central zone of the bottle 16 so that no part of this solution can flow through the cannula 17, whatever the position of the device and the vials
  • FIG. 4H represents a phase during which the syringe 24 is disconnected from the device 10. It will be noted in particular that during this disconnection the needle remains fixed at the end of the syringe, after having been withdrawn from the tip transfer 19 The device 10 is neutralized after the Luer cap 19a has been fitted at the end of the nozzle 19
  • FIG. 41 diagrammatically represents the transfer of the reconstituted drug solution withdrawn by means of the syringe 24 into an infusion bag 31
  • FIG. 4J schematically represents the transfer of the medicinal solution withdrawn by means of the syringe 24 into another container, for example a vial 44
  • FIGS. 5A to 5H corresponds substantially to that of FIGS. 1A to 1H in which the bottle 15 containing a liquid substance, in particular a diluent, has been replaced by a glass bulb sealed with flame. Consequently, the device 10 shown by FIG. 5A is substantially identical, at least as regards the functional aspect of the device represented by FIG. 1A However, the housing 13 which is intended to receive a bulb 50 (see FIG. 5B), has a construction adapted to the shape and dimensions of this ampoule As previously, the device 10 is intended to receive containers, in this case the ampoule 50 containing the diluent and the bottle 16 containing an active substance, in the pre-assembled state.
  • housings 13 and 14 include sealing beads 7 and the central element 12 of the device is fitted with the nozzle 9 provided with the vent filter 8 whose functions have been described previously, which communicates only with the housing 14 by the conduit 9b It will be noted that the conduit 9a has been removed and that the end of the cannula 17 is interrupted at the base of the housing 13, and that this base of the housing comprises an antiparticulate filter 6 separating the housing 13 from the cannula 17
  • FIG. 5C represents the storage phase or the initial phase of use of the device, its containers being pre-assembled
  • FIG. 5D represents the activation phase due to the exercise of a push P1 on the bulb 50 and a push P2 on the bottle 16
  • the neck of the latter must be broken This break can be carried out before mounting the bulb 50 in its housing 13, or even, the contents of the bulb can be emptied in the housing 13 so that 'it rests on the a ⁇ tiparticulate filter 6
  • the breakage of the bulb is preferably obtained thanks to the existence of a stop 60 disposed inside the housing 13, this stop 60 having a ramp 61 which has the effect of repelling the end of the neck of the bulb, the body of which is held firmly inside the housing 13, causing the hedge to fracture between the neck and the body and thereby the opening of this bulb
  • the anti-particle filter 6 or sterilizing filtration which equips the bottom of the housing 13 makes it possible to retain the glass particles or to sterile filter the solution of the bulb which flows through this filter through the channel 17
  • the sterilizing filter becomes an imperative in the case where the solution of the ampoule is poured manually into the housing 13 which forms, in this case, a filtration receptacle
  • the reconstruction phase represented by FIG. 5E is carried out as previously using a syringe 24 • yy
  • Phase 5F represents the balancing of pressures inside the system. It will be noted that a dead volume of diluent remains trapped inside the neck of the ampoule. It will of course be necessary to take this dead volume into account when dosing. of the quantity of solvent initially contained in the ampoule
  • the transfer phase of the reconstituted drug solution is represented by FIG. 5G It is carried out by aspiration using the syringe 24 It will be noted that the dead volume, initially present in the cervix of the ampoule, drops to the bottom of this ampoule during the inversion of the system and cannot mix with the reconstituted solution
  • the final phase of neutralization of the system is obtained by replacing the Luer cap 19a on the nozzle 19
  • the device is provided with housings 13 and 14 intended to receive the two vials 15 and 16 or the ampoule 50 and the vial 16
  • housings 13 and 14 intended to receive the two vials 15 and 16 or the ampoule 50 and the vial 16
  • These housings have essentially two functions, namely to provide guidance containers during their installation and during activation, and ensuring their maintenance during storage for pre-assembled systems, or during the other phases of use
  • FIGS. 6A to 6C associated with two bottles 15 and 16 closed by caps 20 and 21 can also achieve the objective set by the present invention
  • the device 10 represented by FIG. 6A consists of a single element 112 made of synthetic material which carries a cannula 17 and a conduit 18 which opens into a transfer nozzle 19 closed during storage by a Luer cap 19a
  • Two support elements 70 , 71 designed as two transverse discs relative to the axis of the cannula 17, are arranged on either side of the transfer nozzle 19 and serve as support for the two bottles in the phases of use
  • FIG. 6C an activation phase, represented by FIG. 6C, which begins with the placing of the bottles 15, 16 of FIG. 6B in a manner centered on the support elements 70, 71 following the piercing of the plugs 20 and 21 by means of the tips of the cannula 17
  • FIG. 6C an activation phase
  • Such a system can have faults if some precautions are not taken at the start and during use It is necessary to center the tips of the cannula well when placing the vials It is also necessary to maintain the vials during use, in particular to avoid accidental withdrawal of the tips of the cannula from the caps
  • the device 10 has the same components as that of FIG. 6A, but the two tips of the cannula 17 each comprise a retaining member 80, respectively 81, in the form of a harpoon as shown in FIG. 7A
  • This device is arranged to cooperate with two bottles 15 and 16 (fig 7B), identical to those described above
  • FIG. 7C takes place as in the embodiment of FIG. 6C
  • the retaining members 80 and 81 in the form of harpoons are locked against the internal faces of the plugs 20 and 21 and thereby prevent withdrawal accidental vials relative to the tips of the cannula 17
  • the device and the cannula are made in one piece from an injected synthetic material.
  • FIGS. 8A to 8C Another embodiment is shown in FIGS. 8A to 8C.
  • This variant is a mixed solution between the pre-assembled system and the system to be assembled by the end user.
  • the device 10 comprises a body 11 with a central element 12 which carries the cannula 17 and a support element forming a housing 14 in which is pre-assembled a bottle 16 containing the active substance.
  • this bottle is closed by the stopper 20 which is covered with a cap 20a made of plastic, for example a material having a certain flexibility and capable of sealing with the internal bead provided for this purpose.
  • One of the tips of the cannula 17 has a harpoon-shaped retaining member 80.
  • the housing 14 comprises a stop element 90 in the form of a discontinuous stop, which prevents accidental activation of the system, a bead antibacterial 81 which constitutes said antibacterial barrier, a non-return element 92 in the form of discontinuous tabs which prevents accidental withdrawal of the bottle 16 from the housing 14 and finally a blocking element 93 in the form of discontinuous stop which prevents movement of the bottle 16 relative to the housing, after the placement of this bottle in the activated position (see FIG. 8C)
  • the other tip of the cannula 17 is, in the storage position of the system represented by FIG. 8A, masked by a cap 94, sealing and forming an antibacterial barrier with the cannula 17, which will have to be removed to allow the placement of the bottle 15.
  • the phases of use are substantially the same as those already described.
  • This latter variant may be of interest to manufacturers since it is very easy to assemble the transfer device and the bottle containing the active substance and then to carry out the final control and labeling without having to combine bottles from different production lines
  • the diluent can be autoclave, controlled and labeled according to conventional methods and equipment
  • the guidance of the bottle containing the active substance, for which the tip of the cannula is longest, is ensured, which is particularly advantageous since the end of the cannula must be positioned so central
  • the seal between the housings and the bottles can also be obtained by an O-ring attached at the neck and the bottle.
  • the bottle containing the active substance it is essential that its dimensions are determined in such a way that, whatever its position, the reconstituted solution can never penetrate into the centrally placed cannula
  • FIGS. 9A, 9B and 9C show the bottle 16 in three different positions
  • the surface of the solution always remains tangent to a central space 100 which surrounds the end of the cannula, and which is never crossed by the surface 101 defining the level of the liquid
  • the internal volume of the bottle 16 is greater than twice the volume of the reconstituted mixture
  • the conduit 18 is present under the forms an annular passage formed all around the needle 17 which facilitates the flow of the reconstituted solution
  • FIGS. 10A and 10B corresponds to a pre-assembled system comprising the device 10 already described and the housings 13 and 14 intended to receive the bottles 15 and 16 respectively.
  • FIG. 11 represents a variant according to which the device 10 is provided with two housings 13 and 14 intended respectively to receive two ampoules 150 and 160 sealed with flame.
  • the ampoule 150 contains a solvent and the ampoule 160 contains a solid substance, for example example a lyophilizer
  • a syringe 170 is already mounted on the device, the transfer nozzle 19 being appropriately designed
  • the insertion of the ampoules is carried out after rupture of their narrowed neck, in a manner known per se
  • the inner duct 171 which replaces the needle 17 of the embodiment according to Figures 1, is not beveled and is made in one piece with the entire device 10 Its manufacture is therefore particularly economical
  • FIG. 12 illustrates a mixed variant in which the device 10 is provided with housings 13 and 14 designed to receive respectively an ampoule 150 containing the solvent and a vial 16 containing the solid active substance
  • the syringe 170 is preassembled L needle 17 is double Its points are closed and have radial openings 171 and 172
  • Figure 13 illustrates the variant of Figure 12 when the bottle 16 and the ampoule 150 are in place in their housings
  • Figure 14 illustrates the mixing phase of the device as shown in Figures 12 and 13.
  • the reconstituted solution is in the bottle 16, the ampoule 150 being emptied of its content
  • the bottle 16 containing the reconstituted solution is found overturned above the flow conduit which ensures communication with the syringe 170 Traction on the piston rod of this syringe allows to suck the solution
  • FIGS. 16A, 16B, 16C, 16D and 16E illustrate the phases of use of an alternative embodiment of the device according to the invention
  • the device 10 is designed to receive in its two housings 13, 14 a bulb 150 sealed with a flame and containing the solvent and a bottle 16 containing the solid active substance Furthermore, the device is associated with an empty cartridge 200, which is on hold II is closed at its distal end by a plug 201 set
  • FIG. 16B shows the device 10 when the bottle 16 and the bulb 150 are in place
  • FIG. 16C shows the device 10 after mixing.
  • a pull represented by the arrow T shows the displacement of the empty bottle 200 which creates the vacuum allowing the solvent to flow into the bottle
  • the expanded gas resulting from the traction T (see FIG. 16C) coming from the empty cartridge 200, from the bottle 16 and from the bulb 150, can flow into the bottle 16 and in the bulb 150 by a thrust or a suction of gas, as illustrated by the arrow T '
  • the empty cartridge 200 is found in the initial position of FIG. 16B, which has the effect of restoring the balanced atmospheric pressure uniformly in bottle 16 and ampoule 150
  • a pull represented by the arrow T ensures the transfer of the solution in the cartridge 200
  • This bottle is closed at its distal end by the crimped stopper 201 and at its proximal end by a piston-valve 202 which was initially linked to a transfer rod 203 secured to the device 10
  • FIGS. 17A, 17B and 17C illustrate the three phases of use of the bottle 200 prepared as described in FIGS. 16, in combination with a metering and mechanical propulsion system 210, for the injection of predetermined doses. It will be noted that in the embodiment according to Figures 16 and 17, the transfer nozzle 19 of the device 10 is removable and arranged to detach and accompany the cartridge 200 for subsequent use

Abstract

A device (10) for preparing a liquid medicinal solution reconstituted from two components of which at least one is liquid, both components at first being stored in two respective separate sterilised hermetically sealed containers (15, 16). One of the components is an active substance and the other is the active or neutral diluent liquid component. The device comprises a central portion provided with a cannula (17), two container housings (13, 14) on either side of the central portion, and a channel having a first end opening for communication with the container (16) containing said active substance, and a second end opening for connection to a coupling for transferring said reconstituted liquid medicinal substance. The cannula (17) is arranged to establish communication between the two containers placed head-to-tail in the housings (13, 14), and coaxial with said containers, and comprises a first end projecting into the diluent container (15) substantially in the region of the outlet thereof, and a second end projecting into the active substance container (16) substantially in the central portion thereof. The volume of said container is selected to be more than twice the volume of the reconstituted liquid medicinal substance.

Description

DISPOSITIF POUR LA PREPARATION D'UNE SOLUTION MEDICAMENTEUSE RECONSTITUEE A PARTIR DE DEUX COMPOSANTSDEVICE FOR THE PREPARATION OF A RECONSTITUTED MEDICINAL SOLUTION FROM TWO COMPONENTS
La présente invention concerne un dispositif pour la préparation d'une solution médicamenteuse liquide reconstituée à partir de deux composants dont l'un au moins est à l'état liquide, les deux composants étant initialement contenus respectivement dans deux conteneurs stérilisés indépendants hermétiquement fermés, l'un au moins de ces composants étant une substance active et l'autre composant étant ledit composant à l'état liquide actif ou diluant neutre, ce dispositif comportant au moins un élément portant une canule pour mettre en communication les deux conteneurs lorsqu'ils sont disposés tête-bêche, montés sur cet élément, et un conduit agencé pour déboucher par un premier orifice dans ledit conteneur contenant ladite substance active et pour aboutir, par un second orifice, à un embout de transfert de ladite substance médicamenteuse liquide reconstituéeThe present invention relates to a device for the preparation of a liquid medicinal solution reconstituted from two components, at least one of which is in the liquid state, the two components being initially contained respectively in two independent sterilized containers hermetically closed, l at least one of these components being an active substance and the other component being said component in the active liquid state or neutral diluent, this device comprising at least one element carrying a cannula for bringing the two containers into communication when they are arranged head to tail, mounted on this element, and a conduit arranged to open through a first orifice in said container containing said active substance and to lead, through a second orifice, to a transfer nozzle for said reconstituted liquid medicinal substance
Il est bien connu que de nombreuses substances médicamenteuses destinées à être administrées par injection ou au goutte-à-goutte sont relativement instables en solution et ne peuvent être utilisées qu'à l'état reconstitué immédiatement avant leur usage Ces solutions sont préparées par un mélange de deux composants de base qui sont l'un une substance active et l'autre un diluant liquide Ce diluant peut être neutre ou, dans certains cas, il peut également être un composant actif La substance active peut être un liquide ou un lyophilisât, une poudre, des granulés ou peut présenter tout autre aspect physique Les composants sont stockés dans des flacons hermétiquement fermés ou dans des ampoules de verre scellées à la flamme, stérilisées et préservées de tout contact avec une autre substance ou l'environnement extérieur La méthode la plus classique pour préparer le mélange ou la solution de la substance active dans le diluant, consiste à procéder manuellement A cet effet, on utilise généralement une seringue à l'aide de laquelle on perfore le bouchon qui obture le flacon du diluant et on prélève ce diluant pour l'introduire après perforation du bouchon dans le flacon de la substance active Après agitation de ce flacon pour assurer l'homogénéité de la solution, cette dernière peut être prélevée au moyen de la même seringue ou d'une autre seringue en vue de son utilisation ultérieure La solution est ensuite soit injectée directement au patient, soit transférée dans une poche de perfusion ou dans tout autre réservoir appropriéIt is well known that many medicinal substances intended to be administered by injection or drip are relatively unstable in solution and can only be used in the reconstituted state immediately before their use. These solutions are prepared by a mixture of two basic components which are one an active substance and the other a liquid diluent This diluent can be neutral or, in certain cases, it can also be an active component The active substance can be a liquid or a lyophilisate, a powder, granules or may have any other physical aspect The components are stored in hermetically sealed vials or in glass vials sealed with flame, sterilized and preserved from any contact with another substance or the external environment The most conventional method for preparing the mixture or the solution of the active substance in the diluent, consists in manually proceeding to this effect, one generally uses a syringe using which one punctures the stopper which closes the vial of the diluent and this diluent is taken to introduce it after puncturing the stopper in the bottle of the active substance After shaking this bottle to ensure the homogeneity of the solution, the latter can be withdrawn using the same syringe or another syringe for later use The solution is then either injected directly into the patient, or transferred to an infusion bag or other suitable reservoir
Ces manipulations sont complexes et leur fiabilité est totalement dépendante de la qualification du personnel soignant Le risque médical en cas d'erreur de manipulation est loin d'être négligeable En outre, le prélèvement direct de la solution reconstituée dans le flacon qui a servi à effectuer le mélange n'est pas exempt de risque, vu que la perforation des bouchons ou le bris de l'embout en verre d'une ampoule scellée génère des particules qui peuvent, de cas en cas, être injectées dans l'organisme du patient et provoquer des accidents tels que par exemple des emboliesThese manipulations are complex and their reliability is completely dependent on the qualification of the nursing staff. The medical risk in the event of handling error is far from being negligible. In addition, the direct withdrawal of the reconstituted solution from the bottle used to carry out the mixture is not without risk, since the perforation of the caps or the breaking of the glass tip of a sealed ampoule generates particles which can, in certain cases, be injected into the patient's body and cause accidents such as embolism for example
Enfin, le système étant en surpression, le retrait de la seringue peut provoquer des projections contaminantes, à moins d'utiliser une aiguille de seringue de construction spéciale pourvue d'un. évent ou d'une soupape bidirectionnelle avec un seuil d'ouverture prédéterminé et, dans certains cas, d'une garde ou d'un système de soupape qui ne s'ouvre que lorsque l'aiguille est connectée à un flacon, à une poche de perfusion ou similaireFinally, the system being overpressure, the withdrawal of the syringe can cause contaminating projections, unless using a syringe needle of special construction provided with a. vent or a two-way valve with a predetermined opening threshold and, in some cases, a guard or a valve system that opens only when the needle is connected to a vial, to a pocket infusion or similar
L'aiguille de la seringue utilisée pour effectuer le transfert est une aiguille hypodermique qui devra être changée entre les deux opérations qui consistent l'une à reconstituer la solution et l'autre a injecter cette solution selon les prescriptions définies par les règles d'hygiène médicale Dans certains cas le diluant peut déjà être contenu dans une seringue préremplie qu'il suffit de connecter au flacon de substance active pour effectuer la reconstitution et le transfert du mélange dans la seringue Si la totalité du mélange n'est pas transférée dans la seringue, il règne une surpression dans le système, surpression qui provoquera des projections contaminantes lors de la séparation de la seringue et du flaconThe needle of the syringe used to carry out the transfer is a hypodermic needle which will have to be changed between the two operations which consist one of reconstituting the solution and the other has to inject this solution according to the prescriptions defined by the rules of hygiene medical In some cases the diluent may already be contained in a pre-filled syringe which it is sufficient to connect to the bottle of active substance to effect the reconstitution and the transfer of the mixture into the syringe If the whole mixture is not transferred into the syringe, there is an overpressure in the system, overpressure which will cause contaminating projections during the separation of the syringe and the vial
Une autre manière d'effectuer le mélange consiste à utiliser un dispositif tel que décrit par le brevet luxembourgeois No D 34 322 et appelé couramment "set de transfert", qui comporte deux conduits parallèles tenus par une collerette centrale perpendiculaire aux deux conduits Les deux premières extrémités de ces conduits sont agencées pour être introduites dans un premier flacon contenant par exemple une substance active, et les deux autres extrémités de ce conduit sont agencées pour être introduites dans un second flacon contenant le diluant Les flacons sont poussés tête-bêche l'un en direction de l'autre jusqu'à ce que leurs cols respectifs soient en appui contre les deux faces de la collerette centrale Le diluant s'écoule par gravité du flacon qui le contient initialement dans celui qui contient la substance active à travers l'un des deux conduits parallèles, le gaz du flacon contenant la substance active étant évacué à travers le deuxième conduit vers le flacon du diluantAnother way of carrying out the mixing consists in using a device as described by the Luxembourg patent No D 34 322 and commonly called "transfer set", which comprises two parallel conduits held by a central flange perpendicular to the two conduits The first two ends of these conduits are arranged to be introduced into a first vial containing for example an active substance, and the other two ends of this conduit are arranged to be introduced into a second vial containing the diluent The vials are pushed upside down one in the direction of the other until their respective necks are in abutment against the two faces of the central flange The diluent flows by gravity from the bottle which initially contains it into the one which contains the active substance through one of the two parallel conduits, the gas from the bottle containing the active substance being evacuated through the second conduit towards the e bottle of thinner
La solution médicamenteuse parentérale reconstituée à partir des deux composants de base se trouve dans le flacon qui contenait initialement la substance active d'où elle peut être prélevée après retrait du set de transfert, au moyen d'une seringue par aspiration, après perforation du bouchon du flacon au moyen de l'aiguille hypodermique de cette seringueThe parenteral medicinal solution reconstituted from the two basic components is in the bottle which initially contained the active substance, from which it can be withdrawn after removal from the transfer set, using a syringe by aspiration, after puncturing the cap. of the vial using the hypodermic needle of this syringe
Ces opérations sont dangereuses en raison du risque de contamination de l'opérateur par la solution médicamenteuse Une des priorités que s'est fixée l'industrie pharmaceutique sous la pression du corps médical et des instances d'homologation, est la mise au point d'un système permettant la préparation extemporanée sans surpression de solutions médicamenteuses parentérales et stériles sans recours à une ou plusieurs seringues pour y faire transiter un composant liquide avant reconstitution, faisant intervenir une ou plusieurs aiguilles hypodermiques Les conditions imposées par ces instances tendent à interdire les manipulations à risque pour le personnel soignant, étant donné que la solution reconstituée contient des produits à forte activité pharmacologique, notamment des produits anti-cancer, des antibiotiques, des vaccins, des hormones, qui peuvent, le cas échéant, contaminer les médecins ou les infirmièresThese operations are dangerous because of the risk of contamination of the operator by the drug solution. One of the priorities that the pharmaceutical industry has set for itself under pressure from the medical profession and the regulatory authorities, is the development of a system allowing extemporaneous preparation without overpressure of parenteral and sterile medicinal solutions without recourse to or several syringes for passing a liquid component there before reconstitution, involving one or more hypodermic needles The conditions imposed by these bodies tend to prohibit risky handling for nursing staff, given that the reconstituted solution contains products with high activity pharmacological, including anti-cancer products, antibiotics, vaccines, hormones, which may, if necessary, contaminate doctors or nurses
Il existe dans le commerce plusieurs systèmes à deux chambres qui contiennent respectivement une substance active et un solvant, les deux composants pouvant être mélangés par suite de l'ouverture d'un bouchon d'obturation qui sépare initialement les deux chambresSeveral two-chamber systems exist commercially which contain an active substance and a solvent respectively, the two components being able to be mixed as a result of the opening of a closure plug which initially separates the two chambers
La demande de brevet PCT/CH93/00282 décrit un système à deux chambres qui sont constituées par deux conteneurs distincts dont l'un contient la substance active et l'autre le diluant Dans cette réalisation le diluant peut être stérilisé par la chaleur puis associé aseptiquement et de manière étanche au conteneur contenant la substance active Un tel dispositif, s'il est attrayant pour l'utilisateur final, présente l'inconvénient d'être coûteux pour le fabricant et représente un investissement lourd pour l'industrie pharmaceutiquePatent application PCT / CH93 / 00282 describes a two-chamber system which consists of two separate containers, one of which contains the active substance and the other of the diluent. In this embodiment, the diluent can be sterilized by heat and then aseptically combined. and tightly sealed to the container containing the active substance. Such a device, if it is attractive to the end user, has the disadvantage of being costly for the manufacturer and represents a heavy investment for the pharmaceutical industry.
La plupart des autres systèmes à deux chambres ont l'inconvénient de ne pas permettre une stérilisation thermique du diluant vu qu'il se trouve dans le même appareil que la substance active De ce fait, le diluant non stérilisé doit être filtré stérilement et produit aseptiquement Le risque de contamination bactérienne du diluant filtré stérilement est de un pour mille alors que celui du diluant stérilisé par voie thermique est de un pour un millionMost other two-chamber systems have the disadvantage of not allowing thermal sterilization of the diluent since it is in the same device as the active substance. Therefore, the unsterilized diluent must be sterile filtered and produced aseptically. The risk of contamination of the sterile filtered diluent is one per thousand while that of the thermally sterilized diluent is one per million
Une autre manière de procéder au transfert d'une solution entre deux flacons consiste à utiliser une aiguille à double pointe équipée ou non d'un filtre, le flacon devant recevoir la solution à transférer étant déjà sous vide Le système a les inconvénients suivants . le flacon de mélange doit être conditionné et obturé sous vide, le vide doit être maintenu dans le temps, ce qui est difficile de garantir, - l'utilisateur doit tout d'abord coupler le flacon contenant la solution à transférer et ensuite coupler le flacon sous vide, si l'utilisateur ne respecte pas ces séquences, il court le risque de perdre le vide et de se trouver dans l'impossibilité de réaliser son mélange; - un tel système se substitue au set de transfert en utilisant la gravité; lorsque le mélange est réalisé, il faut déconnecter la double aiguille et ponctionner le mélange avec une seringue et une aiguille de manière classique.Another way of transferring a solution between two bottles consists in using a double-pointed needle, whether or not equipped with a filter, the bottle having to receive the solution to be transferred being already under vacuum. The system has the following drawbacks. the mixing bottle must be packaged and sealed under vacuum, the vacuum must be maintained over time, which is difficult to guarantee, - the user must first couple the bottle containing the solution to be transferred and then couple the bottle under vacuum, if the user does not respect these sequences, he runs the risk of losing the vacuum and being unable to carry out his mixing; - such a system replaces the transfer set using gravity; when mixing is done, disconnect the double needle and puncture the mixture with a syringe and needle in the conventional way.
Ce produit est commercialisé sous le nom "Transfert Devices via Direct Vacuum" par la société Braun Médical Inc. Un autre article de cette société permet de transférer le contenu d'une ampoule dans un flacon sous vide au moyen d'un tube souple connecté à l'ampoule, se terminant par une aiguille avec filtre pour perforer le bouchon du flacon sous vide Les inconvénients sont les mêmes que ci-dessus.This product is marketed under the name "Transfer Devices via Direct Vacuum" by the company Braun Médical Inc. Another article of this company allows to transfer the contents of an ampoule in a vacuum bottle by means of a flexible tube connected to the ampoule, ending with a needle with filter to perforate the stopper of the vacuum flask The disadvantages are the same as above.
Le dispositif illustrant l'art antérieur le plus proche est décrit dans le brevet US-2,584,397. Il comporte un support mélangeur rotatif conçu pour permettre de mélanger les contenus respectifs de deux flacons montés sur ce support. Les transferts de l'un des composants de son flacon dans le flacon contenant l'autre composant et du mélange vers une seringue, s'effectuent à travers un circuit étanche Le dispositif permet notamment la reconstitution extemporanée d'une solution médicinale et son transfert dans une seringueThe device illustrating the closest prior art is described in patent US-2,584,397. It includes a rotating mixer support designed to allow the respective contents of two bottles mounted on this support to be mixed. Transfers from one of the components of its vial to the vial containing the other component and from the mixture to a syringe, are carried out through a sealed circuit The device allows in particular the extemporaneous reconstitution of a medicinal solution and its transfer in a syringe
Le transfert de la solution reconstituée dans la seringue ne peut cependant pas s'effectuer en toute sécurité En effet, vu la configuration de l'aiguille à l'intérieur du flacon qui contient la solution reconstituée, la solution peut retourner dans ce flacon, alors qu'elle se trouve dans la chambre de transfert qui communique avec la seringueThe transfer of the reconstituted solution into the syringe cannot however be carried out in complete safety. Indeed, given the configuration of the needle inside the vial which contains the reconstituted solution, the solution can return to this vial, then that it is in the transfer chamber which communicates with the syringe
Au moment où l'utilisateur exerce une traction sur le piston de la seringue, il génère une dépression dans les deux flacons due à l'écoulement de la solution vers la seringue. Si l'utilisateur relâche la traction sur le piston, la dépression crée un rappel de liquide vers les deux flacons, ce qui a pour effet d'interrompre et de compromettre l'opération de transfert II en résulte un risque de dysfonctionnement qui rend ce système inacceptable dans la pratique.When the user pulls the plunger of the syringe, it generates a vacuum in the two vials due to the flow of the solution to the syringe. If the user releases the traction on the piston, the vacuum creates a liquid booster towards the two bottles, which has the effect of interrupting and compromising the transfer operation II resulting in a risk of malfunction which makes this system unacceptable in practice.
Actuellement l'industrie pharmaceutique continue à utiliser les conteneurs standards pour conditionner à la fois les substances actives et les diluants La seule voie possible pour résoudre le problème de sécurité du transfert consiste à associer aux flacons un set de transfert qui permet de connecter de manière étanche le flacon contenant la substance active, le flacon contenant le diluant et une seringue de prélèvement de la solution reconstituée, l'ensemble formant un circuit étanche et étant conçu pour assurer la reconstitution extemporanée de la solution et son transfert dans une seringue sans utilisation d'une aiguille hypodermique et sans générer de surpression susceptible de détruire la molécule et/ou de provoquer des contaminations par projections, nébulisations ou pulvérisations.Currently the pharmaceutical industry continues to use standard containers to package both active substances and diluents. The only possible way to solve the transfer safety problem is to associate with the bottles a transfer set which allows to tightly connect the vial containing the active substance, the vial containing the diluent and a syringe for withdrawing the reconstituted solution, the assembly forming a sealed circuit and being designed to ensure the extemporaneous reconstitution of the solution and its transfer into a syringe without the use of a hypodermic needle and without generating an overpressure capable of destroying the molecule and / or of causing contamination by projections, nebulizations or sprays.
Ce but est atteint par le dispositif selon l'invention caractérisé en ce que ladite canule est disposée coaxialement par rapport aux deux conteneurs montés tête-bêche et comporte une première extrémité qui débouche à l'intérieur dudit conteneur contenant ledit diluant sensiblement à proximité de son embouchure et une seconde extrémité qui débouche dans ledit conteneur contenant la substance active en un point sensiblement central, et en ce que le volume intérieur de ce conteneur est déterminé de manière qu'il soit supérieur au double du volume de la substance médicamenteuse liquide reconstituée Ladite seconde extrémité de ladite canule est située dans une zone centrale, définie comme étant l'espace central dudit conteneur contenant la substance active, qui n'est jamais traversée par la surface définissant le niveau supérieur de la substance médicamenteuse reconstituée dans ce conteneur, quelle que soit la position de ce dernierThis object is achieved by the device according to the invention characterized in that said cannula is arranged coaxially with respect to the two containers mounted head to tail and has a first end which opens out at the interior of said container containing said diluent substantially near its mouth and a second end which opens into said container containing the active substance at a substantially central point, and in that the interior volume of this container is determined so that it is greater than twice the volume of the reconstituted liquid drug substance Said second end of said cannula is located in a central zone, defined as being the central space of said container containing the active substance, which is never crossed by the surface defining the upper level of the drug substance reconstituted in this container, regardless of the position of the latter
Selon une première forme de réalisation avantageuse, au moins ladite seconde extrémité de la canule présente une ouverture biseautée s'étendant sur une hauteur déterminée, et cette hauteur est inférieure à la plus petite dimension de la section la plus petite dudit espace centralAccording to a first advantageous embodiment, at least said second end of the cannula has a beveled opening extending over a determined height, and this height is less than the smallest dimension of the smallest section of said central space
Selon une variante dérivant de la première forme de réalisation, l'une au moins desdites première et seconde extrémités de la canule comporte un organe de retenue en forme de harpon, agencé pour se bloquer contre la face intérieure d'un bouchon d'un conteneur, après la mise en place de ces derniers en position tête-bêche sur le dispositif, ce conteneur au moins étant constitué par un flacon obturé par un bouchon pouvant être percé par ladite seconde extrémité de la canuleAccording to a variant deriving from the first embodiment, at least one of said first and second ends of the cannula comprises a harpoon-shaped retaining member, arranged to lock against the inner face of a cap of a container , after the introduction of the latter in head-to-tail position on the device, this container at least being constituted by a bottle closed by a stopper which can be pierced by said second end of the cannula
Selon une deuxième forme de réalisation avantageuse, le dispositif comporte au moins un élément de support définissant un logement de retenue et de guidage pour au moins ledit conteneur contenant la substance active et recevant ladite seconde extrémité de la canuleAccording to a second advantageous embodiment, the device comprises at least one support element defining a retaining and guide housing for at least said container containing the active substance and receiving said second end of the cannula
Selon une forme de réalisation préférentielle, le dispositif comporte un premier élément de support définissant un premier logement de retenue et de guidage agencé pour recevoir un premier conteneur contenant ledit composant à l'état liquide, et un second élément de support définissant un second logement de retenue et de guidage agence pour recevoir un second conteneur contenant ladite substance activeAccording to a preferred embodiment, the device comprises a first support element defining a first retaining and guide housing arranged to receive a first container containing said component in the liquid state, and a second support element defining a second retaining and guide housing arranged to receive a second container containing said active substance
Dans le cadre de cette forme de réalisation préférentielle, lesdits premier et second conteneurs sont des flacons ayant un col rétréci obturé par un bouchon en un matériau élastomère, et lesdits premier et second logements comportent respectivement une zone de section rétrécie définissant des epaulements, cette zone de section rétrécie étant conçue pour recevoir le col rétréci des flacons au moment de t'activation du système composé du dispositif et des flacons mis en place dans les logements respectifs, et les epaulements étant agencés pour servir d'appui aux corps de ces flaconsIn the context of this preferred embodiment, said first and second containers are bottles having a narrowed neck closed by a stopper made of an elastomeric material, and said first and second housings respectively comprise a zone of narrowed section defining shoulders, this zone of narrowed section being designed to receive the narrowed neck of the vials at the time of activation of the system composed of the device and of the vials placed in the respective housings, and the shoulders being arranged to serve as support for the bodies of these vials
Pour permettre le prémontage des flacons, lesdits logements sont pourvus d'au moins un joint d'étanchéité formant une barrière étanche et antibactéπenne entre les parois extérieures des conteneurs et les parois intérieures des logementsTo allow the pre-assembly of the bottles, said housings are provided with at least one seal forming a tight and antibacterial barrier between the outer walls of the containers and the inner walls of the housings
Dans ie cas où les flacons sont prémontés, le dispositif comporte un second embout disposé dans l'axe de l'embout de transfert, dans un élément central du corps de ce dispositif, ce second embout étant connecté par des conduits respectifs auxdites zones de section rétrécie desdits logementsIn the case where the bottles are pre-assembled, the device comprises a second end-piece arranged in the axis of the transfer end-piece, in a central element of the body of this device, this second end-piece being connected by respective conduits to said cross-section areas narrowed of said dwellings
D'une façon avantageuse le second embout comporte un filtre formant un évent antibactérienAdvantageously, the second nozzle has a filter forming an antibacterial vent
D'une façon préférée, l'un au moins desdits logements comporte des moyens pour permettre un prémontage de l'un desdits conteneurs, ces moyens comprenant un élément d'arrêt empêchant une activation accidentelle du système, un bourrelet antibactérien, un élément anti-retour et un élément de blocage empêchant le retrait du conteneur après l'activation Selon une autre forme de réalisation du dispositif, lorsque le conteneur contenant le composant liquide est une ampoule de verre scellée à la flamme, la zone de section rétrécie du logement destiné à recevoir ce conteneur comporte une butée avec une rampe destinées à briser un col de cette ampoule pour libérer le liquide qu'elle contientPreferably, at least one of said housings comprises means for allowing a pre-assembly of one of said containers, these means comprising a stop element preventing accidental activation of the system, an antibacterial bead, an anti- return and a blocking element preventing removal of the container after activation According to another embodiment of the device, when the container containing the liquid component is a glass ampoule sealed with flame, the narrowed section area of the housing intended to receive this container comprises a stop with a ramp intended to break a neck of this bulb to release the liquid it contains
Selon un mode de construction avantageux, l'embout de transfert peut être terminé par un cône Luer femelle et agencé pour permettre la connexion d'une seringue ayant un embout Luer mâleAccording to an advantageous construction method, the transfer tip can be terminated by a female Luer cone and arranged to allow the connection of a syringe having a male Luer tip.
Dans une réalisation particulière l'embout de transfert peut être équipé d'une aiguille agencée pour permettre la connexion avec une poche de perfusionIn a particular embodiment the transfer nozzle can be equipped with a needle arranged to allow connection with an infusion bag
Selon une autre construction avantageuse, l'embout de transfert peut contenir une aiguille de seringue agencée pour être connectée à une seringue en vue de l'activation du système et du transfert de la solution reconstituéeAccording to another advantageous construction, the transfer tip can contain a syringe needle arranged to be connected to a syringe for activation of the system and transfer of the reconstituted solution
Lorsque le conteneur est une ampoule en verre, le logement comporte un filtre antibactérien agencé pour filtrer le composant liquide avant son transfert à travers la canule dans le flacon contenant la substance activeWhen the container is a glass ampoule, the housing includes an antibacterial filter arranged to filter the liquid component before its transfer through the cannula into the bottle containing the active substance
Selon une forme de réalisation avantageuse, ledit embout de transfert est agencé pour contenir un réceptacle constitué par une seringue, une cartouche vide ou similaire Dans ce cas, l'embout est de préférence amovible en vue d'une utilisation en combinaison avec ladite cartouche videAccording to an advantageous embodiment, said transfer nozzle is designed to contain a receptacle constituted by a syringe, an empty cartridge or the like. In this case, the nozzle is preferably removable for use in combination with said empty cartridge.
Selon une autre forme de réalisation, l'un au moins desdits logements est agencé pour recevoir une ampoule scellée à la flammeAccording to another embodiment, at least one of said housings is arranged to receive a flame-sealed bulb
L'invention sera mieux comprise en référence a la description de plusieurs formes de réalisation du dispositif selon l'invention et au dessin annexé dans lequel les figures 1A à 1 H représentent une première forme de réalisation du dispositif selon l'invention et les différentes phases de son utilisation cette réalisation se prêtant au prémontage des flacons, - les figures 2A à 21 représentent une variante de réalisation du dispositif de l'invention et des phases d'utilisation de cette construction, cette réalisation se prêtant au prémontage des flacons,The invention will be better understood with reference to the description of several embodiments of the device according to the invention and to the accompanying drawing in which FIGS. 1A to 1 H represent a first embodiment of the device according to the invention and the different phases of its use, this embodiment lending itself to the pre-assembly of the bottles, - FIGS. 2A to 21 represent an alternative embodiment of the device of the invention and phases of use of this construction, this embodiment lending itself to the pre-assembly of the bottles,
la figure 3 représente une forme de réalisation dans laquelle les flacons ne sont pas prémontés,FIG. 3 represents an embodiment in which the bottles are not pre-assembled,
les figures 4A à 4J représentent une autre forme de réalisation comportant un embout avec une aiguille prémontée,FIGS. 4A to 4J represent another embodiment comprising a tip with a pre-assembled needle,
- les figures 5A à 5H représentent une variante selon laquelle l'un des flacons est remplacé par une ampoule en verre scellée à la flamme,FIGS. 5A to 5H represent a variant according to which one of the bottles is replaced by a glass bulb sealed with flame,
les figures 6A à 6C représentent une forme de réalisation simplifiée dans laquelle les moyens de guidage et de retenue des flacons sont supprimés,FIGS. 6A to 6C represent a simplified embodiment in which the means for guiding and retaining the bottles are eliminated,
les figures 7A à 7C représentent une variante de la réalisation selon les figures 6A à 6C,FIGS. 7A to 7C represent a variant of the embodiment according to FIGS. 6A to 6C,
- les figures 8A à 8C représentent une variante selon laquelle un logement de maintien et de guidage est prévu pour le flacon contenant la substance active,FIGS. 8A to 8C show a variant in which a holding and guiding housing is provided for the bottle containing the active substance,
les figures 9A à 9C représentent la position relative du flacon et de l'extrémité de la canule lorsque le flacon est orienté dans diverses positions, les figures 10A et 10B représentent une variante destinée au prémontage des flacons, l'étanchéité étant assurée par un joint toriqueFIGS. 9A to 9C represent the relative position of the bottle and of the end of the cannula when the bottle is oriented in various positions, FIGS. 10A and 10B represent a variant intended for the pre-assembly of the bottles, the sealing being ensured by an O-ring
la figure 11 présente une variante du dispositif dans laquelle les logements sont conçus pour recevoir des ampoules scellées à la flamme, la figure 12 représente une autre variante du dispositif destiné à recevoir une ampoule et un flacon,FIG. 11 shows a variant of the device in which the housings are designed to receive flame-sealed ampoules, FIG. 12 shows another variant of the device intended to receive an ampoule and a bottle,
les figures 13, 14 et 15 représentent les phases d'utilisation du dispositif de la figure 12,FIGS. 13, 14 and 15 represent the phases of use of the device of FIG. 12,
les figures 16A, 16B, 16C, 16D et 16E représentent une variante du dispositif selon l'invention, dans une utilisation particulière, etFIGS. 16A, 16B, 16C, 16D and 16E show a variant of the device according to the invention, in a particular use, and
- les figures 17A, 17B et 17C représentent une utilisation d'un flacon initialement préparé par le dispositif selon les figures 16- Figures 17A, 17B and 17C show a use of a bottle initially prepared by the device according to Figures 16
En référence aux figures 1A à 1 H, le dispositif 10 pour la préparation d'une solution médicamenteuse reconstituée à partir de deux composants se compose principalement d'un corps 1 1 , de préférence réalisé par moulage en matière thermoplastique comprenant un élément central 12 et deux éléments de support définissant deux logements de retenue et de guidage 13 et 14 disposés de part et d'autre dudit élément central, et destinés à recevoir respectivement deux conteneurs, par exemple deux flacons stérilisés 15 et 16 (voir figure 1 B) indépendants Ces deux flacons 15 et 16 sont hermétiquement fermés et contiennent l'un (15) une substance liquide, par exemple un diluant, et l'autre (16) une substance active, par exemple un lyophilisât susceptible d'être dissout par le diluant II est à noter que l'un des flacons (par exemple 15) contient toujours une substance liquide, mais que cette substance peut être un composant actif, ou un solvant neutre La substance dite active contenue par exemple dans le flacon 16 peut être liquide, pâteuse ou avoir toute autre consistance appropriée pourvu qu'elle puisse se dissoudre dans le liquide de l'autre flaconWith reference to FIGS. 1A to 1 H, the device 10 for the preparation of a medicinal solution reconstituted from two components mainly consists of a body 11, preferably produced by molding in thermoplastic material comprising a central element 12 and two support elements defining two retaining and guide housings 13 and 14 arranged on either side of said central element, and intended to receive respectively two containers, for example two sterilized bottles 15 and 16 (see FIG. 1 B) independent of these two vials 15 and 16 are hermetically sealed and contain one (15) a liquid substance, for example a diluent, and the other (16) an active substance, for example a lyophilisate capable of being dissolved by the diluent II is note that one of the bottles (for example 15) always contains a liquid substance, but that this substance can be an active component, or a neutral solvent The substance says e active contained for example in the bottle 16 can be liquid, pasty or any other suitable consistency as long as it can dissolve in the liquid in the other bottle
L'élément central 12 porte une canule 17 qui s'étend des deux côtes dans les logements 13 et 14 et un conduit 18 qui débouche dans le logement 14 par un de ses orifices et dans un embout de transfert 19 par un second orifice L'embout de transfert est par exemple équipé d'un capuchon Luer 19a Les deux logements 13 et 14 comportent chacun une zone de section rétrécie 13a, 14a qui définissent respectivement avec le reste des parois de ces logements un épaulement 13b, 14b, dont le rôle sera décrit par la suite L'élément central 12 comporte également, dans cette réalisation un second embout 9, disposé sensiblement dans le prolongement de l'embout de transfert 19, selon le même axe, cet embout ayant une fonction d'évent antibactérien et étant équipé à son extrémité d'un filtre 8 approprié Cet évent communique par deux conduits 9a et 9b respectivement avec les logements de retenue et de guidage 13 et 14 De ce fait, l'air contenu dans ces logements et qui est emprisonné dans les logements, plus précisément dans les têtes de ces logements, lorsque les flacons 15 et 16 sont prémontés, peut s'échapper En effet, dans ie cas de flacons prémontés, en particulier, les deux logements 13 et 14 sont équipés d'une ceinture intérieure ou de bourrelets 7 qui assurent l'étanchéité et forment une barrière antibactérienne pour éviter le cheminement de bactéries vers les éléments actifs du dispositif et vers les têtes des flacons Ce même objectif justifie également la présence du filtre 8 sur le second embout 9The central element 12 carries a cannula 17 which extends on both sides in the housings 13 and 14 and a conduit 18 which opens into the housing 14 through one of its orifices and into a transfer nozzle 19 through a second orifice L ' transfer tip is for example equipped with a Luer cap 19a The two housings 13 and 14 each have a narrowed section zone 13a, 14a which respectively define with the rest of the walls of these housings a shoulder 13b, 14b, whose role will be described below The central element 12 also comprises, in this embodiment a second endpiece 9, disposed substantially in the extension of the transfer endpiece 19, along the same axis, this endpiece having an antibacterial vent function and being equipped at its end of a suitable filter 8 This vent communicates by two conduits 9a and 9b respectively with the retaining and guide housings 13 and 14 Therefore, the air contained in these housings and which is trapped sounded in the housings, more precisely in the heads of these housings, when the bottles 15 and 16 are pre-assembled, can escape Indeed, in the case of pre-assembled bottles, in particular, the two housings 13 and 14 are equipped with an inner belt or beads 7 which seal and form an antibacterial barrier to prevent the passage of bacteria towards the active elements of the device and towards the heads of the bottles. This same objective also justifies the presence of the filter 8 on the second end piece 9
Le dispositif de l'invention, représenté dans une forme de réalisation préférentielle, est illustré par la figure 1 C dans sa première phase d'utilisation ou sa phase de stockage II est destiné a être utilisé avec deux flacons tels que ceux représentés par la figure 1 B Ces flacons 15, 16 sont obturés par des bouchons 20, 21 en élastomère sertis par des capsules en aluminium 22, 23 qui constituent ensemble une barrière hermétique et aseptique Les deux flacons sont stérilisés, le flacon 16 par exemple au cours du processus de lyophilisation de la substance active qu'il contient, et le flacon 15 par un processus thermique tout à fait courant L'utilisation de ce système à trois éléments commence par une phase d'assemblage des deux flacons 15 16 et du dispositif 10, qui consiste à mettre en place le flacon 15 du solvant dans le logement 13 du dispositif et le flacon 16 de la substance active dans le logement 14 On remarque que les flacons ne sont introduits dans les logements que jusqu'aux pointes de la canule 17, sans que les bouchons 20 et 21 soient perforés Dans l'exemple représenté, les flacons sont prémontés et la figure 1 C représente une position de stockage d'un système prémonté comprenant le dispositif 10 et les deux conteneurs 15 et 16The device of the invention, represented in a preferred embodiment, is illustrated by FIG. 1C in its first phase of use or its storage phase II is intended to be used with two bottles such as those represented in the figure 1 B These bottles 15, 16 are closed by plugs 20, 21 made of elastomer crimped by aluminum capsules 22, 23 which together constitute a hermetic and aseptic barrier. The two bottles are sterilized, the bottle 16 for example during the process of freeze-drying of the active substance it contains, and the bottle 15 by a very common thermal process The use of this three-element system begins with a phase of assembly of the two bottles 15 16 and of the device 10, which consists to put in place the vial 15 of the solvent in the housing 13 of the device and the vial 16 of the active substance in the housing 14 It is noted that the vials are introduced into the housings only up to the tips of the cannula 17, without the plugs 20 and 21 are perforated In the example shown, the bottles are pre-assembled and FIG. 1C represents a storage position for a pre-assembled system comprising the device 10 and the two containers 15 and 16
L'étape suivante représentée par la figure 1 D consiste à exercer une poussée respectivement P1 et P2 sur les fonds des flacons 15 et 16 pour que les pointes de la canule 17 perforent les bouchons 20 et 21 et que les extrémités de la canule pénètrent respectivement à l'intérieur des flacons 15 et 16 L'air contenu dans les logements 13 et 14 s'échappe par les conduits 9a et 9b et par le filtre évent 8, sous la poussée des flacons qui restent étanches grâce aux ceintures 7 des logements 13 et 14 pendant toute la phase d'activation Dans cette phase, le système est activé On notera que cette activation est réalisée lorsque les cols des flacons sont engagés dans les zones de section rétrécie 13a et 14a des logements et que les parois des corps des flacons sont en appui contre les epaulements 13b et 14b définis ci-dessusThe next step represented by FIG. 1 D consists in exerting a push respectively P1 and P2 on the bottoms of the bottles 15 and 16 so that the tips of the cannula 17 perforate the plugs 20 and 21 and that the ends of the cannula penetrate respectively inside the bottles 15 and 16 The air contained in the housings 13 and 14 escapes through the conduits 9a and 9b and through the vent filter 8, under the pressure of the bottles which remain sealed thanks to the belts 7 of the housings 13 and 14 during the entire activation phase In this phase, the system is activated. It will be noted that this activation is carried out when the necks of the bottles are engaged in the zones of narrowed section 13a and 14a of the housings and the walls of the bodies of the bottles. are in abutment against the shoulders 13b and 14b defined above
Au cours de l'étape suivante représentée par la figure 1E, une seringue d'aspiration 24 comportant un corps 25, un piston 26, une tige de piston 27 couplée au piston 26 et un embout porte-aiguille 28 agencé pour être adapté à l'embout de transfert 19, est couplée au dispositif 10 Une traction exercée sur la tige de piston 27 provoque une aspiration qui se traduit par une dépression à l'intérieur du flacon 16, l'aspiration de l'air ou du gaz contenu dans le flacon 16 s'effectuant à travers le conduit 18 Grâce à cette dépression, le diluant contenu dans le flacon 15 s'écoule dans le flacon 16 à travers la canule 17 La solution issue du mélange des deux composants se retrouve dans le flacon 16 Des que la totalité du diluant s'est écoulée dans le flacon 16, la dépression dans le système s'équilibre à travers la canule 17 et le conduit 18During the next step represented by FIG. 1E, a suction syringe 24 comprising a body 25, a plunger 26, a plunger rod 27 coupled to the plunger 26 and a needle holder tip 28 arranged to be adapted to the transfer nozzle 19, is coupled to the device 10 A traction exerted on the piston rod 27 causes a suction which results in a vacuum inside the bottle 16, the suction of the air or gas contained in the bottle 16 is carried out through the conduit 18 Thanks to this depression, the diluent contained in the bottle 15 flows into the bottle 16 through the cannula 17 The solution resulting from the mixture of the two components found in the bottle 16 As soon as all of the diluent has flowed into the bottle 16, the vacuum in the system is balanced through the cannula 17 and the conduit 18
La pointe de la canule 17 qui se trouve a l'intérieur du flacon 16 se trouve au- dessus de la surface de la solution contenue dans ce flacon après l'opération consistant à dissoudre le lyophilisât dans le diluant, cette opération étant appelée phase de reconstitution En outre, cette pointe occupe une position telle que, quelle que soit la position du flacon, la surface sensiblement plane qui définit le niveau de la solution reste toujours en dessous de cette pointe pour que la solution ne puisse jamais s'écouler à travers la canule 17The tip of the cannula 17 which is inside the bottle 16 is located above the surface of the solution contained in this bottle after the operation consisting in dissolving the lyophilisate in the diluent, this operation being called phase of reconstitution In addition, this tip occupies a position such that, whatever the position of the bottle, the substantially flat surface which defines the level of the solution always remains below this tip so that the solution can never flow through cannula 17
L'étape suivante, représentée par la figure 1 F consiste à recharger les flacons 15 et 16 qui étaient en dépression sous l'action du vide créé par la traction de la tige du piston 27 de la seringue 24, en rétablissant la pression atmosphérique dans ces flacons et en supprimant le vide partiel dans la seringue 24 afin que celle-ci soit capable de recevoir la solution reconstituée Ce rétablissement de la pression atmosphérique dans le système se fait grâce à la seringue 24 dont on relâche ia traction sur la tige du piston 27 qui se fait aspirer par le vide régnant dans les flacons 15 et 16 On peut également aider ce retour de piston pour combler les forces de friction en poussant mécaniquement sur la tige du piston 27 Dès que cette tige du piston a atteint son point de départ avant aspiration, la pression atmosphérique est rétablie dans les flacons 15 et 16, dans la canule 17 et dans le conduit 18The next step, represented by FIG. 1 F, consists in refilling the bottles 15 and 16 which were under vacuum under the action of the vacuum created by the pulling of the piston rod 27 of the syringe 24, by restoring atmospheric pressure in these vials and removing the partial vacuum in the syringe 24 so that it is capable of receiving the reconstituted solution This recovery of atmospheric pressure in the system is done using the syringe 24 which is released ia traction on the piston rod 27 which is sucked up by the vacuum prevailing in the bottles 15 and 16 We can also help this piston return to compensate for the friction forces by mechanically pushing on the piston rod 27 As soon as this piston rod has reached its starting point before suction, atmospheric pressure is restored in the vials 15 and 16, in the cannula 17 and in the conduit 18
Pour prélever la solution, comme le montre la figure 1 G, ou une certaine quantité de solution au moyen de la seringue 24, on retourne le dispositif, de telle manière que le flacon 16 se trouve au-dessus du flacon 15 L'embout porte-aiguille 28, et par conséquent la seringue, est ainsi en communication avec l'intérieur du flacon 16 par l'intermédiaire du conduit 18 La solution peut être aspirée par la seringue 24 qui peut prélever jusqu'à la dernière goutte de liquide étant donné que le conduit 18 débouche à l'intérieur du flacon 15 a ras du bouchon 21 Une légère dépression se produit dans les deux flacons qui restent en communication De ce fait, lorsque la seringue est détachée de l'embout de transfert 19, aucun liquide ne risque de s'échapper et de contaminer le personnel soignant, vu que les résidus liquides sont réaspirés dans les flacons où règne une dépression Cette légère dépression existe dès le moment où les premières gouttes de solution sont aspirées dans la seringue Cette dépression ne peut jamais être importante, car elle s'équilibre automatiquement dans les deux flacons à travers la canule 17 Cela permet à l'utilisateur de ne prélever qu'une petite partie de la solution reconstituée en mesurant précisément cette quantité au moyen de la seringue et de détacher cette seringue du dispositif à n'importe quel stade du prélèvement sans aucun risque de contaminationTo withdraw the solution, as shown in FIG. 1G, or a certain quantity of solution by means of the syringe 24, the device is turned over, so that the bottle 16 is located above the bottle 15 The endpiece carries needle 28, and consequently the syringe, is thus in communication with the interior of the bottle 16 via the conduit 18. The solution can be drawn up by syringe 24 which can draw up to the last drop of liquid since the conduit 18 opens into the interior of the vial 15 flush with the stopper 21 A slight depression occurs in the two vials which remain in communication As a result, when the syringe is detached from the transfer nozzle 19, no liquid is likely to escape and contaminate the nursing staff, since the liquid residues are sucked back into the bottles where there is a depression This slight depression exists from the moment when the first drops of solution are drawn into the syringe This depression does not can never be important, because it automatically balances in the two vials through the cannula 17 This allows the user to withdraw only a small part of the reconstituted solution by precisely measuring this quantity using the syringe and detach this syringe from the device at any stage of collection without any risk of contamination
Le fait que les deux flacons communiquent entre eux pour équilibrer la dépression par la canule 17 est un avantage très important qui permet l'existence de la dépression sans que celle-ci soit trop importante En effet, si cette communication entre les deux flacons par la canule 17 n'existait pas, le vide qui serait généré dans le seul flacon 16 lors de l'opération de prélèvement serait très rapidement important et forcerait l'utilisateur à maintenir une traction importante sur la tige du piston 27 avant la séparation, ce qui rendrait l'opération de mesure très difficile Mais puisque la dépression est faible, celle-ci exerce une force faible sur le piston de la seringue, voisine de la force de friction de ce piston II n'est donc pas nécessaire d'exercer une traction importante pour prélever et mesurer une quantité prédéterminée de solution reconstituée On peut même interrompre cette traction au moment de la séparation, sans risque de perdre la précision de la dose mesuréeThe fact that the two bottles communicate with each other to balance the depression by the cannula 17 is a very important advantage which allows the existence of the depression without it being too great. Indeed, if this communication between the two bottles by the cannula 17 did not exist, the vacuum which would be generated in the only bottle 16 during the sampling operation would be very quickly important and would force the user to maintain a significant traction on the piston rod 27 before separation, which would make the measurement operation very difficult But since the depression is low, it exerts a weak force on the syringe piston, close to the friction force of this piston II is therefore not necessary to exert a traction important for withdrawing and measuring a predetermined quantity of reconstituted solution This traction can even be interrupted at the time of separation, without risk of losing the precision of the d dare measured
La figure 1H montre le système vide après usage Le capuchon Luer 19a a été replacé sur l'embout de transfert 19 Les figures 2A à 21 illustrent une variante de réalisation selon laquelle le dispositif 10 est pourvu d'une aiguille prémontée 30 agencée pour assurer le transfert de la solution reconstituée dans une poche de transfusion 31 ou similaire En l'occurrence, l'élément central 12 du dispositif est pourvu d'un embout de transfert 19 relativement long qui se compose d'un support fixe portant l'aiguille 30 et d'une pièce tubulaire amovible 32 assurant étanchéité avec l'aiguille 30, initialement obturée par un capuchon Luer 33 Tous les autres composants du dispositif 10 et notamment les logements 13 et 14 sont, à quelques détails de forme près, identiques à ceux décrits précédemment De même, les flacons 15 et 16 ont des formes et des fonctions voisines à celles décrites en référence à la figure 1 B, bien que les bouchons d'obturation 20 et 21 présentent quelques différences constructivesFigure 1H shows the system empty after use The Luer cap 19a has been replaced on the transfer nozzle 19 FIGS. 2A to 21 illustrate an alternative embodiment according to which the device 10 is provided with a pre-assembled needle 30 arranged to ensure the transfer of the reconstituted solution into a transfusion bag 31 or the like. In this case, the central element 12 of the device is provided with a relatively long transfer nozzle 19 which consists of a fixed support carrying the needle 30 and a removable tubular part 32 ensuring sealing with the needle 30, initially closed by a Luer cap 33 All the other components of the device 10 and in particular the housings 13 and 14 are, apart from a few details of shape, identical to those described previously Similarly, the bottles 15 and 16 have shapes and functions similar to those described with reference to the figure 1 B, although the plugs 20 and 21 have some constructive differences
La phase de mise en place des flacons ou, dans certains cas, la phase de stockage, représentée par la figure 2C, la phase d'activation de la figure 2D, la phase de reconstitution de la solution médicamenteuse à partir des deux composants, représentée par la figure 2E, la phase d'équilibrage des pressions représentée par la figure 2F, la phase d'aspiration représentée par la figure 2G et la phase de séparation et de neutralisation du système telle que représentée par la figure 2H, sont pratiquement identiques aux phases correspondantes des figures 1 C à 1 HThe phase of placing the vials or, in certain cases, the storage phase, represented by FIG. 2C, the activation phase of FIG. 2D, the phase of reconstitution of the drug solution from the two components, represented in FIG. 2E, the pressure balancing phase represented by FIG. 2F, the suction phase represented by FIG. 2G and the phase of separation and neutralization of the system as represented by FIG. 2H, are practically identical to the corresponding phases of figures 1 C to 1 H
La phase de transfert de la totalité du mélange ou du solde de ce mélange restant après prélèvement d'une certaine quantité au cours de la phase d'aspiration représentée par la figure 2G, dans une poche de transfusion 31 ou similaire s'effectue lorsque l'aiguille 30 est mise à nu suite au retrait de la pièce tubulaire amovible 32 Le transfert se fait grâce à la mise en pression du système par l'exercice d'une pression sur la poche qui transfère de l'air sous pression dans les flacons Après relâchement de cette poussée sur la poche, la surpression régnant dans le système provoque l'écoulement de la solution dans la poche La reconstitution et le transfert de la solution vers la poche de transfusion 31 ou similaire peuvent se faire directement en mettant l'aiguille 30 à nu dès le début et en connectant cette aiguille à la poche 31 avant reconstitution sans passer par les phases 2E, 2F, 2G et 2H qui recourent à une seringue intermédiaireThe transfer phase of the entire mixture or of the balance of this mixture remaining after withdrawal of a certain quantity during the aspiration phase represented by FIG. 2G, into a transfusion bag 31 or the like takes place when the needle 30 is exposed after the removal of the removable tubular part 32 The transfer is made by pressurizing the system by applying pressure to the bag which transfers pressurized air into the bottles After releasing this pressure on the pocket, the overpressure prevailing in the system causes the solution to flow into the pocket The reconstitution and the transfer of the solution to the transfusion bag 31 or similar can be done directly by exposing the needle 30 from the start and by connecting this needle to the bag 31 before reconstitution without going through the phases 2E, 2F , 2G and 2H which use an intermediate syringe
Le mélange se fait grâce à la mise en pression du système par l'exercice d'une poussée sur la poche qui transfère de l'air dans les flacons, le flacon de diluant étant dirigé vers le haut Après relâchement de cette pression sur la poche, il se crée une dépression dans le flacon de reconstitution et le diluant s'écoule par la canule Le transfert se fait de la même façon que ci-dessus, mais en prenant soin de diriger le flacon contenant la solution reconstituée vers le haut La construction du système représenté par les figures 2A à 21 présente les avantages suivants - la reconstitution et le transfert peuvent se faire au moyen d'une seringue afin de prélever une petite partie de la solution reconstituée dans la seringue, tel que représenté par la figure 2H et d'injecter cette petite dose en bolus à un patient, le reste de la solution peut être transféré dans une poche de perfusion, - dans le cas où il n'est pas nécessaire d'injecter une petite dose en bolus, l'utilisation de la seringue est inutile et la totalité du mélange peut être reconstituée grâce à la poche et transférée dans cette poche en circuit fermé Cette combinaison de possibilités serait impossible à réaliser s'il existait une pièce mobile du type robinet entre les deux flacons, qui obligerait le transit du solvant avant reconstitution dans une seringueThe mixing is done by putting the system under pressure by exerting a push on the pocket which transfers air into the bottles, the diluent bottle being directed upwards After this pressure is released on the pocket , a vacuum is created in the reconstitution bottle and the diluent flows through the cannula Transfer is done in the same way as above, but taking care to direct the bottle containing the reconstituted solution upwards Construction of the system represented by FIGS. 2A to 21 has the following advantages - the reconstitution and the transfer can be done by means of a syringe in order to withdraw a small part of the reconstituted solution in the syringe, as represented by FIG. 2H and to inject this small bolus dose to a patient, the rest of the solution can be transferred to an infusion bag, - in case it is not necessary to inject a small bolus dose , the use of the syringe is unnecessary and the entire mixture can be reconstituted using the bag and transferred to this bag in a closed circuit This combination of possibilities would be impossible to achieve if there was a moving part of the tap type between the two vials, which would require the transit of the solvent before reconstitution in a syringe
La figure 3 représente une variante de réalisation du dispositif tel que le montre la figure 1A Comme il est destiné à une utilisation sans prémontage, les logements 13 et 14 ne présentent pas de ceinture ou de bourrelets pour former une barrière étanche antibactérienne 11 existe entre les parois des logements et celles des flacons suffisamment de jeu pour permettre à l'air de s'échapper lors de la mise en place de ces flacons De ce fait, l'embout 9 avec son filtre évent 8 ont été supprimés puisqu'ils ne se justifient pas dans ce cas Par ailleurs, toutes les phases d'utilisation postérieures à la mise en place des flacons, sont identiques à celles décrites en référence aux figures 1A à 1 H Les mêmes pièces portent les mêmes références que celles de la figure 1AFIG. 3 represents an alternative embodiment of the device as shown in FIG. 1A As it is intended for use without pre-assembly, the housings 13 and 14 do not have a belt or beads to form a waterproof antibacterial barrier 11 exists between the walls of the housings and those of the bottles sufficient clearance to allow the air to escape when these bottles are put in place. As a result, the nozzle 9 with its vent filter 8 have been eliminated since they are not justified in this case. Furthermore, all the phases of use after the placement of the bottles, are identical to those described with reference to FIGS. 1A to 1 H The same parts have the same references as those of FIG. 1A
La variante de réalisation représentée par les figures 4A à 4J dérive des formes de réalisation précédentes et les pièces identiques à des composants déjà décrits portent les mêmes numéros de référence En référence à ces figures, le dispositif 10 comporte comme précédemment un corps 11 avec un élément central 12 et deux éléments de support et de guidage 13 et 14 Etant donné que ce dispositif est destiné au prémontage des deux flacons 15 et 16 illustrés par le figure 4B, les logements 13 et 14 comportent des bourrelets 7 formant à la fois un joint d'étanchéité et une barrière antibactérienne entre les parois intérieures des logements et les parois extérieures des flaconsThe variant embodiment shown in FIGS. 4A to 4J derives from the previous embodiments and the parts identical to components already described have the same reference numbers. With reference to these figures, the device 10 comprises, as before, a body 11 with an element central 12 and two support and guide elements 13 and 14 Given that this device is intended for pre-assembly of the two bottles 15 and 16 illustrated in FIG. 4B, the housings 13 and 14 include beads 7 forming both a gasket and an antibacterial barrier between the interior walls of the housings and the exterior walls of the bottles
Dans cette réalisation, comme dans celle qui est représentée en référence aux figures 2A à 21, l'élément central 12 du dispositif est pourvu d'un embout de transfert 19 relativement long, de forme sensiblement cylindrique, et qui se termine par un tronçon d'extrémité 40, tronconique agencé pour recevoir un élément porte-aiguille 41 , par exemple du type cône Luer, qui porte effectivement une aiguille 42 logée dans l'embout de transfert 19 L'élément porte-aiguille 41 est obturé par un capuchon Luer 19a identique à ceux décrits précédemment On notera que l'embout de transfert 19 comporte une bague intérieure 43, de préférence en un matériau élastomère, qui assure à la fois le centrage, le maintien en position et l'étanchéité au niveau de cette aiguille, lorsqu'elle est logée, comme le montre précisément la figure 4A à l'intérieur de l'embout de transfert 19 Comme mentionné précédemment, lorsque le dispositif est destiné au prémontage du flacon, un second embout 9 équipé d'un filtre évent 8 s'avère nécessaireIn this embodiment, as in that which is shown with reference to FIGS. 2A to 21, the central element 12 of the device is provided with a relatively long transfer nozzle 19, of substantially cylindrical shape, and which ends in a section d end 40, frustoconical arranged to receive a needle-carrying element 41, for example of the Luer cone type, which effectively carries a needle 42 housed in the transfer nozzle 19 The needle-carrying element 41 is closed by a Luer cap 19a identical to those described above. It will be noted that the transfer nozzle 19 has an inner ring 43, preferably made of an elastomeric material, which ensures both centering, holding in position and sealing at the level of this needle, when '' it is housed, as shown precisely in Figure 4A inside the transfer nozzle 19 As mentioned above, when the device is intended for pre-assembly of the bottle, a second nozzle 9 equipped with a vent filter 8 is necessary
La figure 4C représente le dispositif dans une position initiale, qui est de préférence sa position de stockage, dans laquelle les flacons de la figure 4B sont prémontés dans les logements 13 et 14FIG. 4C represents the device in an initial position, which is preferably its storage position, in which the bottles of FIG. 4B are pre-assembled in the housings 13 and 14
La figure 4D représente la phase d'activation dans laquelle l'utilisateur a exercé une poussée respectivement P1 sur le flacon 15 contenant le diluant et une poussée P2 sur le flacon 16 contenant la substance active de manière à mettre les deux flacons en communication à travers la canule 17 dont les pointes ont respectivement perforé les bouchons 20 et 21 Le gaz contenu dans les logements 13, 14 s'échappe par les conduits 9a et 9b et par le filtre 8 sous la poussée des flacons qui restent étanches grâce à la ceinture 7.FIG. 4D represents the activation phase in which the user has exerted respectively a push P1 on the bottle 15 containing the diluent and a push P2 on the bottle 16 containing the active substance so as to put the two bottles in communication through the cannula 17, the tips of which have respectively punctured the plugs 20 and 21 The gas contained in the housings 13, 14 escapes through the conduits 9a and 9b and through the filter 8 under the pressure of the bottles which remain sealed thanks to the belt 7 .
Après retrait du capuchon Luer 19a et la connexion d'une seringue 24, pourvue d'un corps 25 d'un piston 26 et d'une tige de piston 27, sur l'élément porte-aiguille à l'extrémité de l'embout de transfert 19 (figure 4E), le transfert du solvant contenu dans le flacon 15 dans le flacon 16 en vue de la reconstitution de la solution médicamenteuse, peut être effectué Cette opération s'effectue suite à la création d'un vide à l'intérieur du flacon 16 dû à une aspiration de l'air qu'il contient à travers le conduit 18 au moyen de la seringue 24After removal of the Luer cap 19a and connection of a syringe 24, provided with a body 25 with a piston 26 and a piston rod 27, on the needle-holder element at the end of the nozzle transfer 19 (FIG. 4E), the transfer of the solvent contained in the vial 15 into the vial 16 for the purpose of reconstituting the drug solution can be carried out This operation is carried out following the creation of a vacuum at the inside of the bottle 16 due to a suction of the air which it contains through the conduit 18 by means of the syringe 24
La figure 4F représente l'équilibrage des pressions dans les deux flacons qui communiquent entre eux au moyen de la canule 17FIG. 4F represents the balancing of the pressures in the two bottles which communicate with each other by means of the cannula 17
La figure 4G représente une phase de prélèvement d'une partie de la solution reconstituée Pour effectuer ce prélèvement, une partie du mélange est aspirée au moyen de la seringue, le dispositif ayant au préalable été retourné de telle manière que le flacon 16 contenant la solution reconstituée se trouve en haut et que la solution puisse s'écouler à travers le conduit 18 On notera que l'extrémité de la canule 17 est située sensiblement en une zone centrale du flacon 16 de telle manière qu'aucune partie de cette solution ne puisse s'écouler à travers la canule 17, quelle que soit la position du dispositif et des flaconsFIG. 4G represents a phase of sampling part of the reconstituted solution To perform this sampling, part of the mixture is aspirated by means of the syringe, the device having previously been turned over so that the bottle 16 containing the solution reconstructed is found above and that the solution can flow through the conduit 18 It will be noted that the end of the cannula 17 is situated substantially in a central zone of the bottle 16 so that no part of this solution can flow through the cannula 17, whatever the position of the device and the vials
La figure 4H représente une phase au cours de laquelle la seringue 24 est déconnectée du dispositif 10 On notera en particulier qu'au cours de cette déconnexion l'aiguille reste fixée à l'extrémité de la seringue, après avoir été retirée de l'embout de transfert 19 La neutralisation du dispositif 10 s'obtient après la mise en place du capuchon Luer 19a à l'extrémité de l'embout 19FIG. 4H represents a phase during which the syringe 24 is disconnected from the device 10. It will be noted in particular that during this disconnection the needle remains fixed at the end of the syringe, after having been withdrawn from the tip transfer 19 The device 10 is neutralized after the Luer cap 19a has been fitted at the end of the nozzle 19
La figure 41 représente schematiquement le transfert de la solution médicamenteuse reconstituée prélevée au moyen de la seringue 24 dans une poche de perfusion 31FIG. 41 diagrammatically represents the transfer of the reconstituted drug solution withdrawn by means of the syringe 24 into an infusion bag 31
La figure 4J représente schematiquement le transfert de la solution médicamenteuse prélevée au moyen de la seringue 24 dans un autre conteneur, par exemple un flacon 44FIG. 4J schematically represents the transfer of the medicinal solution withdrawn by means of the syringe 24 into another container, for example a vial 44
La réalisation selon les figures 5A à 5H correspond sensiblement à celle des figures 1A à 1 H dans laquelle le flacon 15 contenant une substance liquide, notamment un diluant a été remplacé par une ampoule en verre scellée à la flamme En conséquence, le dispositif 10 représenté par la figure 5A est sensiblement identique, du moins en ce qui concerne l'aspect fonctionnel au dispositif représenté par la figure 1A Toutefois, le logement 13 qui est destiné à recevoir une ampoule 50 (voir figure 5B), présente une construction adaptée à la forme et aux dimensions de cette ampoule Comme précédemment, le dispositif 10 est destiné à recevoir des conteneurs, en l'occurrence l'ampoule 50 contenant le diluant et le flacon 16 contenant une substance active, à l'état prémontés De ce fait, les logements 13 et 14 comportent des bourrelets d'étanchéité 7 et l'élément central 12 du dispositif est équipe de l'embout 9 pourvu du filtre d'évent 8 dont les fonctions ont été décrites précédemment, qui communique uniquement avec le logement 14 par le conduit 9b On notera que le conduit 9a a été supprimé et que l'extrémité de la canule 17 est interrompue au niveau de la base du logement 13, et que cette base du logement comporte un filtre antiparticulaire 6 séparant le logement 13 de la canule 17The embodiment according to FIGS. 5A to 5H corresponds substantially to that of FIGS. 1A to 1H in which the bottle 15 containing a liquid substance, in particular a diluent, has been replaced by a glass bulb sealed with flame. Consequently, the device 10 shown by FIG. 5A is substantially identical, at least as regards the functional aspect of the device represented by FIG. 1A However, the housing 13 which is intended to receive a bulb 50 (see FIG. 5B), has a construction adapted to the shape and dimensions of this ampoule As previously, the device 10 is intended to receive containers, in this case the ampoule 50 containing the diluent and the bottle 16 containing an active substance, in the pre-assembled state. housings 13 and 14 include sealing beads 7 and the central element 12 of the device is fitted with the nozzle 9 provided with the vent filter 8 whose functions have been described previously, which communicates only with the housing 14 by the conduit 9b It will be noted that the conduit 9a has been removed and that the end of the cannula 17 is interrupted at the base of the housing 13, and that this base of the housing comprises an antiparticulate filter 6 separating the housing 13 from the cannula 17
La figure 5C représente la phase de stockage ou la phase initiale d'utilisation du dispositif, ses conteneurs étant prémontésFIG. 5C represents the storage phase or the initial phase of use of the device, its containers being pre-assembled
La figure 5D représente la phase d'activation due à l'exercice d'une poussée P1 sur l'ampoule 50 et d'une poussée P2 sur le flacon 16 A ce propos, il est à noter que pour permettre l'écoulement du diluant contenu dans l'ampoule 50, le col de cette dernière doit être cassé Cette cassure peut être réalisée avant de monter l'ampoule 50 dans son logement 13, ou même, le contenu de l'ampoule peut être vidé dans le logement 13 pour qu'il repose sur le filtre aπtiparticulaire 6 La cassure de l'ampoule est de préférence obtenue grâce à l'existence d'une butée 60 disposée à l'intérieur du logement 13, cette butée 60 présentant une rampe 61 qui a pour effet de repousser l'extrémité du col de l'ampoule dont le corps est maintenu fermement à l'intérieur du iogement 13, entraînant une fracture de la haison entre le col et le corps et de ce fait l'ouverture de cette ampouleFIG. 5D represents the activation phase due to the exercise of a push P1 on the bulb 50 and a push P2 on the bottle 16 In this regard, it should be noted that to allow the flow of the diluent contained in the bulb 50, the neck of the latter must be broken This break can be carried out before mounting the bulb 50 in its housing 13, or even, the contents of the bulb can be emptied in the housing 13 so that 'it rests on the aπtiparticulate filter 6 The breakage of the bulb is preferably obtained thanks to the existence of a stop 60 disposed inside the housing 13, this stop 60 having a ramp 61 which has the effect of repelling the end of the neck of the bulb, the body of which is held firmly inside the housing 13, causing the hedge to fracture between the neck and the body and thereby the opening of this bulb
Le filtre antiparticulaire 6 ou de filtration stérilisante qui équipe le fond du logement 13 permet de retenir les particules de verre ou de filtrer stérilement la solution de l'ampoule qui s'écoule à travers ce filtre par le canal 17 Le filtre stérilisant devient un impératif dans le cas où la solution de l'ampoule est déversée manuellement dans le logement 13 qui forme, dans ce cas, un réceptacle de filtrationThe anti-particle filter 6 or sterilizing filtration which equips the bottom of the housing 13 makes it possible to retain the glass particles or to sterile filter the solution of the bulb which flows through this filter through the channel 17 The sterilizing filter becomes an imperative in the case where the solution of the ampoule is poured manually into the housing 13 which forms, in this case, a filtration receptacle
La phase de reconstitution représentée par la figure 5E s'effectue comme précédemment au moyen d'une seringue 24 yyThe reconstruction phase represented by FIG. 5E is carried out as previously using a syringe 24 yy
La phase 5F représente l'équilibrage des pressions à l'intérieur du système On remarquera qu'un volume mort de diluant reste prisonnier à l'intérieur du col de l'ampoule II conviendra bien entendu de tenir compte de ce volume mort lors du dosage de la quantité de solvant initialement contenu dans l'ampoule La phase de transfert de la solution médicamenteuse reconstituée est représentée par la figure 5G Elle s'effectue par aspiration au moyen de la seringue 24 On notera que le volume mort, initialement présent dans le col de l'ampoule, retombe au fond de cette ampoule lors du retournement du système et ne peut pas se mélanger à la solution reconstituéePhase 5F represents the balancing of pressures inside the system. It will be noted that a dead volume of diluent remains trapped inside the neck of the ampoule. It will of course be necessary to take this dead volume into account when dosing. of the quantity of solvent initially contained in the ampoule The transfer phase of the reconstituted drug solution is represented by FIG. 5G It is carried out by aspiration using the syringe 24 It will be noted that the dead volume, initially present in the cervix of the ampoule, drops to the bottom of this ampoule during the inversion of the system and cannot mix with the reconstituted solution
La phase finale de neutralisation du système, représentée par la figure 5H, est obtenue par la remise en place du capuchon Luer 19a sur l'embout 19The final phase of neutralization of the system, represented by FIG. 5H, is obtained by replacing the Luer cap 19a on the nozzle 19
Dans toutes les formes de réalisation décrites ci-dessus, le dispositif est pourvu des logements 13 et 14 destinés à recevoir les deux flacons 15 et 16 ou l'ampoule 50 et le flacon 16 Ces logements ont essentiellement deux fonctions, à savoir assurer le guidage des conteneurs lors de leur mise en place et pendant l'activation, et assurer leur maintien pendant le stockage pour des systèmes prémontés, ou pendant les autres phases de l'utilisationIn all the embodiments described above, the device is provided with housings 13 and 14 intended to receive the two vials 15 and 16 or the ampoule 50 and the vial 16 These housings have essentially two functions, namely to provide guidance containers during their installation and during activation, and ensuring their maintenance during storage for pre-assembled systems, or during the other phases of use
Il se trouve que la présence des logements constitue une solution de confort, mais non une nécessité absolue pour que le dispositif soit opérationnel En effet, un dispositif tel que représenté par les figures 6A à 6C associé à deux flacons 15 et 16 obturés par des bouchons 20 et 21 peut également atteindre l'objectif fixé par la présente inventionIt turns out that the presence of the housings constitutes a comfort solution, but not an absolute necessity for the device to be operational. Indeed, a device as represented by FIGS. 6A to 6C associated with two bottles 15 and 16 closed by caps 20 and 21 can also achieve the objective set by the present invention
Le dispositif 10 représenté par la figure 6A est constitué d'un élément unique 112 en matière synthétique qui porte une canule 17 et un conduit 18 qui débouche dans un embout de transfert 19 fermé pendant le stockage par un capuchon Luer 19a Deux éléments de support 70, 71 conçus comme deux disques transversaux par rapport à l'axe de la canule 17, sont disposés de part et d'autre de l'embout de transfert 19 et servent d'appui aux deux flacons dans les phases d'utilisationThe device 10 represented by FIG. 6A consists of a single element 112 made of synthetic material which carries a cannula 17 and a conduit 18 which opens into a transfer nozzle 19 closed during storage by a Luer cap 19a Two support elements 70 , 71 designed as two transverse discs relative to the axis of the cannula 17, are arranged on either side of the transfer nozzle 19 and serve as support for the two bottles in the phases of use
L'utilisation commence par une phase d'activation, représentée par la figure 6C, qui commence par une mise en place des flacons 15, 16 de la figure 6B d'une manière centrée sur les éléments de support 70, 71 suite au percement des bouchons 20 et 21 au moyen des pointes de la canule 17 Les autres phases d'utilisation sont similaires à celles déjà décritesThe use begins with an activation phase, represented by FIG. 6C, which begins with the placing of the bottles 15, 16 of FIG. 6B in a manner centered on the support elements 70, 71 following the piercing of the plugs 20 and 21 by means of the tips of the cannula 17 The other phases of use are similar to those already described
Un tel système peut présenter des défauts si quelques précautions ne sont pas prises au départ et en cours d'utilisation II est nécessaire de bien centrer les pointes de la canule au moment de la mise en place des flacons II est également nécessaire de maintenir les flacons en cours d'utilisation, notamment pour éviter un retrait accidentel des pointes de la canule hors des bouchonsSuch a system can have faults if some precautions are not taken at the start and during use It is necessary to center the tips of the cannula well when placing the vials It is also necessary to maintain the vials during use, in particular to avoid accidental withdrawal of the tips of the cannula from the caps
Pour éviter partiellement ces inconvénients, il est possible d'associer à la canule des organes de retenue empêchant un retrait des flacons, après leur mise en place Un tel dispositif est représenté par l'ensemble des figures 7A à 7CTo partially avoid these drawbacks, it is possible to associate with the cannula retaining members preventing withdrawal of the vials, after their installation. Such a device is represented by the assembly of FIGS. 7A to 7C
Le dispositif 10 présente les mêmes composants que celui de la figure 6A, mais les deux pointes de la canule 17 comportent chacune un organe de retenue 80, respectivement 81 , en forme de harpon comme le montre la figure 7A Ce dispositif est agencé pour coopérer avec deux flacons 15 et 16 (figue 7B), identiques à ceux décrits précédemmentThe device 10 has the same components as that of FIG. 6A, but the two tips of the cannula 17 each comprise a retaining member 80, respectively 81, in the form of a harpoon as shown in FIG. 7A This device is arranged to cooperate with two bottles 15 and 16 (fig 7B), identical to those described above
L'activation représentée par la figure 7C se fait comme dans l'exemple de réalisation de la figure 6C Les organes de retenue 80 et 81 en forme de harpons se bloquent contre les faces internes des bouchons 20 et 21 et empêchent de ce fait un retrait accidentel des flacons par rapport aux pointes de la canule 17 Dans les deux constructions selon les figures 6 et 7, le dispositif et la canule sont réalisés d'une pièce en une matière synthétique injectéeThe activation represented by FIG. 7C takes place as in the embodiment of FIG. 6C The retaining members 80 and 81 in the form of harpoons are locked against the internal faces of the plugs 20 and 21 and thereby prevent withdrawal accidental vials relative to the tips of the cannula 17 In the two constructions according to FIGS. 6 and 7, the device and the cannula are made in one piece from an injected synthetic material.
Une autre forme de réalisation est représentée par les figures 8A à 8C Cette variante est une solution mixte entre le système prémonté et le système à monter par l'utilisateur final. Dans cette construction, le dispositif 10 comporte un corps 11 avec un élément central 12 qui porte la canule 17 et un élément de support formant un logement 14 dans lequel est prémonté un flacon 16 contenant la substance active. On notera que ce flacon est obturé par le bouchon 20 qui est recouvert d'un capuchon 20a en matière plastique, par exemple un matériau ayant une certaine souplesse et capable d'assurer l'étanchéité avec le bourrelet intérieur prévu à cet effet. Une des pointes de la canule 17 comporte un organe de retenue 80 en forme de harpon. Le flacon 16 étant prémonté, une étanchéité et une barrière bactérienne doivent être prévues dans le logement 14. A cet effet, le logement 14 comporte un élément d'arrêt 90 en forme de butée discontinue, qui empêche une activation accidentelle du système, un bourrelet antibactérien 81 qui constitue ladite barrière antibactérienne, un élément anti-retour 92 en forme de taquets discontinus qui empêche un retrait accidentel du flacon 16 hors du logement 14 et enfin un élément de blocage 93 en forme de butée discontinue qui empêche le déplacement du flacon 16 par rapport au logement, après la mise en place de ce flacon en position activée (voir figure 8C)Another embodiment is shown in FIGS. 8A to 8C. This variant is a mixed solution between the pre-assembled system and the system to be assembled by the end user. In this construction, the device 10 comprises a body 11 with a central element 12 which carries the cannula 17 and a support element forming a housing 14 in which is pre-assembled a bottle 16 containing the active substance. It will be noted that this bottle is closed by the stopper 20 which is covered with a cap 20a made of plastic, for example a material having a certain flexibility and capable of sealing with the internal bead provided for this purpose. One of the tips of the cannula 17 has a harpoon-shaped retaining member 80. The bottle 16 being pre-assembled, a seal and a bacterial barrier must be provided in the housing 14. For this purpose, the housing 14 comprises a stop element 90 in the form of a discontinuous stop, which prevents accidental activation of the system, a bead antibacterial 81 which constitutes said antibacterial barrier, a non-return element 92 in the form of discontinuous tabs which prevents accidental withdrawal of the bottle 16 from the housing 14 and finally a blocking element 93 in the form of discontinuous stop which prevents movement of the bottle 16 relative to the housing, after the placement of this bottle in the activated position (see FIG. 8C)
L'autre pointe de la canule 17 est, dans la position de stockage du système représentée par la figure 8A, masquée par un capuchon 94, assurant l'étanchéité et formant une barrière antibactérienne avec la canule 17, qui devra être retiré pour permettre la mise en place du flacon 15.The other tip of the cannula 17 is, in the storage position of the system represented by FIG. 8A, masked by a cap 94, sealing and forming an antibacterial barrier with the cannula 17, which will have to be removed to allow the placement of the bottle 15.
Les phases d'utilisation sont sensiblement les mêmes que celles déjà décrites. Cette dernière variante peut présenter un intérêt pour les industriels du fait qu'il est très aisé d'assembler le dispositif de transfert et le flacon contenant la substance active puis de procéder au contrôle final et à l'étiquetage sans devoir combiner des flacons provenant de lignes de production différentes En particulier, le diluant peut être autoclave, contrôlé et étiqueté selon des méthodes et sur des équipements classiquesThe phases of use are substantially the same as those already described. This latter variant may be of interest to manufacturers since it is very easy to assemble the transfer device and the bottle containing the active substance and then to carry out the final control and labeling without having to combine bottles from different production lines In particular, the diluent can be autoclave, controlled and labeled according to conventional methods and equipment
En outre, dans cette réalisation, le guidage du flacon contenant la substance active, pour lequel la pointe de la canule est la plus longue, est assuré, ce qui est particulièrement avantageux du fait que l'extrémité de la canule doit se positionner de manière centraleIn addition, in this embodiment, the guidance of the bottle containing the active substance, for which the tip of the cannula is longest, is ensured, which is particularly advantageous since the end of the cannula must be positioned so central
Diverses variantes peuvent encore être imaginées Par exemple, dans les systèmes prémontés, l'étanchéité entre les logements et les flacons peut également être obtenue par un joint torique rapporté au niveau du col et du flaconVarious variants can also be imagined. For example, in pre-assembled systems, the seal between the housings and the bottles can also be obtained by an O-ring attached at the neck and the bottle.
En ce qui concerne le flacon contenant la substance active, il est indispensable que ses dimensions soient déterminées de telle manière que quelle que soit sa position, la solution reconstituée ne puisse jamais pénétrer dans la canule disposée de façon centraleAs regards the bottle containing the active substance, it is essential that its dimensions are determined in such a way that, whatever its position, the reconstituted solution can never penetrate into the centrally placed cannula
Cette condition est illustrée par les figures 9A, 9B et9C qui montrent le flacon 16 dans trois positions différentes Lorsque l'on tourne le flacon dans tous les sens, la surface de la solution reste toujours tangente à un espace central 100 qui entoure l'extrémité de la canule, et qui n'est jamais traversé par la surface 101 définissant le niveau du liquide En fait, le volume intérieur du flacon 16 est supérieur au double du volume du mélange reconstitué On notera en outre que le conduit 18 se présente sous la forme d'un passage annulaire ménagé tout autour de l'aiguille 17 ce qui facilite l'écoulement de la solution reconstituée La variante de réalisation selon les figures 10A et 10B correspond à un système prémonté comportant le dispositif 10 déjà décrit et les logements 13 et 14 destines à recevoir respectivement les flacons 15 et 16 Comme ces flacons sont prémontés, il est nécessaire de prévoir une barrière antibactérienne entre les parois intérieures des logements et les parois extérieures des flacons Cette barrière est réalisée au moyen d'un joint torique 110 qui est logé à la base du col des flacons Dans la position de stockage représentée par la figure 10A, le joint torique 110 est comprimé en raison d'un rétrécissement de diamètre intérieur des logements dans une zone 111 délimitée par deux bourrelets 113 et 114 L'étanchéité et la protection antibactérienne sont assurées dans cette zone qui est suivie par une zone 115 dans laquelle le diamètre est plus grand, ce qui permet d'évacuer l'air contenu à l'intérieur des logements au cours de la phase d'activation Un bourrelet 116 anti-retour assure le blocage en position des flacons après l'activation du systèmeThis condition is illustrated by FIGS. 9A, 9B and 9C which show the bottle 16 in three different positions When the bottle is turned in all directions, the surface of the solution always remains tangent to a central space 100 which surrounds the end of the cannula, and which is never crossed by the surface 101 defining the level of the liquid In fact, the internal volume of the bottle 16 is greater than twice the volume of the reconstituted mixture It will further be noted that the conduit 18 is present under the forms an annular passage formed all around the needle 17 which facilitates the flow of the reconstituted solution The variant embodiment according to FIGS. 10A and 10B corresponds to a pre-assembled system comprising the device 10 already described and the housings 13 and 14 intended to receive the bottles 15 and 16 respectively. As these bottles are pre-assembled, it is necessary to provide an antibacterial barrier between the interior walls of the housings and the exterior walls of the bottles This barrier is produced by means of an O-ring 110 which is housed at the base of the neck of the bottles In the storage position shown in FIG. 10A, the O-ring 110 is compressed due to a narrowing of the internal diameter of the housings in a zone 111 delimited by two beads 113 and 114 The sealing and the antibacterial protection are ensured in this zone which is followed by a zone 115 in which the diameter is larger, which allows the air contained inside the accommodation to be evacuated during the activation phase A bo 116 non-return urrelet ensures the bottles are locked in position after system activation
Grâce à ces différences de diamètres intérieurs des logements et la présence du joint torique 110, il est possible de supprimer l'embout 9 avec son filtre évent 8, l'évacuation de l'air pouvant se faire grâce à du jeu entre les parois des flacons et les logements, et la garantie de l'étanchéité dans certaines zonesThanks to these differences in interior diameters of the housings and the presence of the O-ring 110, it is possible to remove the end piece 9 with its vent filter 8, the evacuation of the air being able to be done thanks to play between the walls of the bottles and housings, and the guarantee of watertightness in certain areas
La figure 11 représente une variante selon laquelle le dispositif 10 est pourvu de deux logements 13 et 14 destinés respectivement à recevoir deux ampoules 150 et 160 scellées à la flamme L'ampoule 150 contient un solvant et l'ampoule 160 contient une substance solide, par exemple un lyophilisant Une seringue 170 est déjà montée sur le dispositif, l'embout de transfert 19 étant conçu de manière appropriée La mise en place des ampoules s'effectue après rupture de leur col rétréci, d'une manière connue en soi On notera que le conduit intérieur 171 qui remplace l'aiguille 17 de la réalisation selon les figures 1 , n'est pas biseaute et est réalisé d'une pièce avec l'ensemble du dispositif 10 Sa fabrication est de ce fait particulièrement économiqueFIG. 11 represents a variant according to which the device 10 is provided with two housings 13 and 14 intended respectively to receive two ampoules 150 and 160 sealed with flame. The ampoule 150 contains a solvent and the ampoule 160 contains a solid substance, for example example a lyophilizer A syringe 170 is already mounted on the device, the transfer nozzle 19 being appropriately designed The insertion of the ampoules is carried out after rupture of their narrowed neck, in a manner known per se It will be noted that the inner duct 171 which replaces the needle 17 of the embodiment according to Figures 1, is not beveled and is made in one piece with the entire device 10 Its manufacture is therefore particularly economical
La figure 12 illustre une variante mixte dans laquelle le dispositif 10 est pourvu de logements 13 et 14 conçus pour recevoir respectivement une ampoule 150 contenant le solvant et un flacon 16 contenant la substance active solide Comme dans la réalisation précédente, la seringue 170 est prémontée L'aiguille 17 est double Ses pointes sont fermées et comportent des ouvertures radiales 171 et 172FIG. 12 illustrates a mixed variant in which the device 10 is provided with housings 13 and 14 designed to receive respectively an ampoule 150 containing the solvent and a vial 16 containing the solid active substance As in the previous embodiment, the syringe 170 is preassembled L needle 17 is double Its points are closed and have radial openings 171 and 172
La figure 13 illustre la variante de la figure 12 lorsque le flacon 16 et l'ampoule 150 sont en place dans leurs logementsFigure 13 illustrates the variant of Figure 12 when the bottle 16 and the ampoule 150 are in place in their housings
La figure 14 illustre la phase de mélange du dispositif tel que représenté par les figures 12 et 13. La solution reconstituée se trouve dans le flacon 16, l'ampoule 150 étant vidée de son contenuFigure 14 illustrates the mixing phase of the device as shown in Figures 12 and 13. The reconstituted solution is in the bottle 16, the ampoule 150 being emptied of its content
Comme le montre la figure 15, après un retournement du dispositif 10, le flacon 16 contenant la solution reconstituée se retrouve renversée au-dessus du conduit d'écoulement qui assure la communication avec la seringue 170 Une traction sur la tige du piston de cette seringue permet d'aspirer la solutionAs shown in FIG. 15, after the device 10 has been turned over, the bottle 16 containing the reconstituted solution is found overturned above the flow conduit which ensures communication with the syringe 170 Traction on the piston rod of this syringe allows to suck the solution
Les figures 16A, 16B, 16C, 16D et 16E illustrent les phases d'utilisation d'une variante de réalisation du dispositif selon l'invention Le dispositif 10 est conçu pour recevoir dans ses deux logements 13, 14 une ampoule 150 scellée à la flamme et contenant le solvant et un flacon 16 contenant la substance active solide Par ailleurs, le dispositif est associé à une cartouche vide 200, qui est en attente II est obturé à son extrémité distale par un bouchon 201 serti La figure 16B montre le dispositif 10 lorsque le flacon 16 et l'ampoule 150 sont en placeFIGS. 16A, 16B, 16C, 16D and 16E illustrate the phases of use of an alternative embodiment of the device according to the invention The device 10 is designed to receive in its two housings 13, 14 a bulb 150 sealed with a flame and containing the solvent and a bottle 16 containing the solid active substance Furthermore, the device is associated with an empty cartridge 200, which is on hold II is closed at its distal end by a plug 201 set FIG. 16B shows the device 10 when the bottle 16 and the bulb 150 are in place
La figure 16C montre le dispositif 10 après le mélange Une traction représentée par la flèche T montre le déplacement du flacon vide 200 qui crée la dépression permettant au solvant de s'écouler dans le flaconFIG. 16C shows the device 10 after mixing. A pull represented by the arrow T shows the displacement of the empty bottle 200 which creates the vacuum allowing the solvent to flow into the bottle
Après un retournement du dispositif 10, illustré par la flèche R, le gaz détendu résultant de ia traction T (voir figure 16C) provenant de la cartouche vide 200, du flacon 16 et de I'ampoule150, peut s'écouler dans le flacon 16 et dans l'ampoule 150 par une poussée ou une aspiration de gaz, telle qu'illustrée par la flèche T' La cartouche vide 200 se retrouve dans la position initiale de la figure 16B, ce qui a pour effet de rétablir la pression atmosphérique équilibrée uniformément dans le flacon 16 et l'ampoule 150After the device 10 has been turned over, illustrated by the arrow R, the expanded gas resulting from the traction T (see FIG. 16C) coming from the empty cartridge 200, from the bottle 16 and from the bulb 150, can flow into the bottle 16 and in the bulb 150 by a thrust or a suction of gas, as illustrated by the arrow T 'The empty cartridge 200 is found in the initial position of FIG. 16B, which has the effect of restoring the balanced atmospheric pressure uniformly in bottle 16 and ampoule 150
Comme le montre la figure 16E, une traction représentée par la flèche T assure le transfert de la solution dans la cartouche 200 Ce flacon est obturé à son extrémité distale par le bouchon serti 201 et à son extrémité proximale par un piston-vanne 202 qui était initialement lié à une tige de transfert 203 solidaire du dispositif 10As shown in FIG. 16E, a pull represented by the arrow T ensures the transfer of the solution in the cartridge 200 This bottle is closed at its distal end by the crimped stopper 201 and at its proximal end by a piston-valve 202 which was initially linked to a transfer rod 203 secured to the device 10
Les figures 17A, 17B et 17C illustrent les trois phases d'utilisation du flacon 200 préparé comme décrit par les figures 16, en combinaison avec un système de dosage et de propulsion mécanique 210, en vue d'une injection de doses prédéterminées On notera que dans la réalisation selon les figures 16 et 17, l'embout de transfert 19 du dispositif 10 est amovible et agencé pour se détacher et accompagner la cartouche 200 en vue d'utilisation ultérieure FIGS. 17A, 17B and 17C illustrate the three phases of use of the bottle 200 prepared as described in FIGS. 16, in combination with a metering and mechanical propulsion system 210, for the injection of predetermined doses. It will be noted that in the embodiment according to Figures 16 and 17, the transfer nozzle 19 of the device 10 is removable and arranged to detach and accompany the cartridge 200 for subsequent use

Claims

REVENDICATIONS
1 Dispositif pour la préparation d'une solution médicamenteuse liquide reconstituée a partir de deux composants dont l'un au moins est à l'état liquide, les deux composants étant initialement contenus respectivement dans deux conteneurs stérilisés indépendants hermétiquement fermés, l'un au moins de ces composants étant une substance active et l'autre composant étant ledit composant à l'état liquide actif ou diluant neutre, ce dispositif comportant au moins un élément (12, 112) portant une canule (17) pour mettre en communication les deux conteneurs lorsqu'ils sont disposés tête- bêche, montés sur ce corps, et un conduit (18) agencé pour déboucher par un premier orifice dans ledit conteneur contenant ladite substance active et pour aboutir, par un second orifice, à un embout de transfert (19) de ladite substance médicamenteuse liquide reconstituée, caractérisé en ce que ladite canule est disposée coaxialement par rapport aux deux conteneurs montés tête-bêche et comporte une première extrémité qui débouche à l'intérieur dudit conteneur contenant ledit diluant sensiblement à proximité de son embouchure et une seconde extrémité qui débouche dans ledit conteneur contenant la substance active en un point sensiblement central, en ce que le volume intérieur de ce conteneur est déterminé de manière qu'il soit supérieur au double du volume de la substance médicamenteuse liquide reconstituée, et en ce que ladite seconde extrémité de ladite canule (17) est située dans une zone centrale, définie comme étant l'espace central (100) dudit conteneur (16) contenant la substance active, qui n'est jamais traversé par la surface (101) définissant le niveau supérieur de la substance médicamenteuse reconstituée dans ce conteneur, quelle que soit la position de ce dernier1 Device for the preparation of a liquid medicinal solution reconstituted from two components, at least one of which is in the liquid state, the two components being initially contained respectively in two independent sterilized containers hermetically closed, at least one of these components being an active substance and the other component being said component in the active liquid or neutral diluent state, this device comprising at least one element (12, 112) carrying a cannula (17) for bringing the two containers into communication when they are arranged head to tail, mounted on this body, and a conduit (18) arranged to open through a first orifice in said container containing said active substance and to lead, through a second orifice, to a transfer nozzle (19 ) of said reconstituted liquid medicinal substance, characterized in that said cannula is arranged coaxially with respect to the two containers mounted head-to-head che and has a first end which opens into the interior of said container containing said diluent substantially near its mouth and a second end which opens into said container containing the active substance at a substantially central point, in that the interior volume of this container is determined so that it is greater than twice the volume of the reconstituted liquid drug substance, and in that said second end of said cannula (17) is located in a central area, defined as the central space (100 ) of said container (16) containing the active substance, which is never crossed by the surface (101) defining the upper level of the drug substance reconstituted in this container, whatever the position of the latter
2 Dispositif selon la revendication 1 , caractérisé en ce qu'au moins ladite seconde extrémité de la canule (17) présente une ouverture biseautée s'étendant sur une hauteur déterminée, et en ce que cette hauteur est inférieure à la plus petite dimension de la section la plus petite dudit espace central (100)2 Device according to claim 1, characterized in that at least said second end of the cannula (17) has a beveled opening extending over a determined height, and in that this height is less than the smallest dimension of the smallest section of said central space (100)
3 Dispositif selon la revendication 1 , caractérisé en ce que l'une au moins desdites première et seconde extrémités de la canule (17) comporte un organe de retenue (80 et/ou 81 ) en forme de harpon, agencé pour se bloquer contre la face intérieure d'un bouchon (20 et/ou 21 ) d'un conteneur (15 et/ou 16), après la mise en place de ces derniers en position tête-bêche sur le dispositif (10), ce conteneur au moins étant constitué par un flacon obturé par un bouchon pouvant être percé par ladite seconde extrémité de la canule (17)3 Device according to claim 1, characterized in that at least one of said first and second ends of the cannula (17) comprises a retaining member (80 and / or 81) in the form of a harpoon, arranged to lock against the inner face of a plug (20 and / or 21) of a container (15 and / or 16), after the positioning of the latter in head-to-tail position on the device (10), this container at least being consisting of a bottle closed by a stopper which can be pierced by said second end of the cannula (17)
4 Dispositif selon la revendication 1 , caractérisé en ce qu'il comporte au moins un élément de support définissant un logement de retenue et de guidage (14) pour au moins ledit conteneur (16) contenant la substance active et recevant ladite seconde extrémité de la canule (17)4 Device according to claim 1, characterized in that it comprises at least one support element defining a retaining and guide housing (14) for at least said container (16) containing the active substance and receiving said second end of the cannula (17)
5 Dispositif selon la revendication 4, caractérisé en ce qu'il comporte un premier élément de support définissant un premier logement de retenue et de guidage (13) agencé pour recevoir un premier conteneur (15, 50) contenant ledit composant à l'état liquide, et un second élément de support définissant un second logement de retenue et de guidage (14) agencé pour recevoir un second conteneur (16) contenant ladite substance active5 Device according to claim 4, characterized in that it comprises a first support element defining a first retaining and guide housing (13) arranged to receive a first container (15, 50) containing said component in the liquid state , and a second support element defining a second retaining and guide housing (14) arranged to receive a second container (16) containing said active substance
6 Dispositif selon la revendication 5, caractérisé en ce que lesdits premier et second conteneurs sont des flacons (15, 16) ayant un col rétréci obturé par respectivement par un bouchon (20, 21 ) en un matériau élastomère, et en ce que lesdits premier et second logements (13, 14) comportent respectivement une zone de section rétrécie (13a, 14a) définissant des epaulements (13b, 14b), cette zone de section rétrécie étant conçue pour recevoir le cols rétréci des flacons (15, 16) au moment de l'activation du système composé du dispositif et des flacons mis en place dans les logements respectifs, et les epaulements étant agencés pour servir d'appui aux corps de ces flacons6 Device according to claim 5, characterized in that said first and second containers are bottles (15, 16) having a narrowed neck closed by respectively by a stopper (20, 21) of an elastomeric material, and in that said first and second housings (13, 14) respectively have a narrowed section area (13a, 14a) defining shoulders (13b, 14b), this narrowed section area being designed to receive the narrowed neck of the bottles (15, 16) at the time of the activation of the system composed of device and bottles placed in the respective housings, and the shoulders being arranged to serve as support for the bodies of these bottles
7 Dispositif selon la revendication 6, caractérisé en ce que lesdits logements (13, 14) sont pourvus d'au moins un joint d'étanchéité (7) formant une barrière étanche et antibactérienne entre les parois extérieures des conteneurs (15, 16) et les parois intérieures des logements (13,14)7 Device according to claim 6, characterized in that said housings (13, 14) are provided with at least one seal (7) forming a tight and antibacterial barrier between the outer walls of the containers (15, 16) and the interior walls of the housings (13,14)
8 Dispositif selon la revendication 1 , caractérisé en ce qu'il comporte un second embout (9) disposé dans l'axe de l'embout de transfert (19), dans l'élément central (12) du corps (11 ) de ce dispositif (10), ce second embout étant connecté par des conduits respectifs (9a, 9b) auxdites zones de section rétrécie (13a, 14a) desdits logements (13, 14)8 Device according to claim 1, characterized in that it comprises a second endpiece (9) disposed in the axis of the transfer endpiece (19), in the central element (12) of the body (11) of this device (10), this second endpiece being connected by respective conduits (9a, 9b) to said zones of narrowed section (13a, 14a) of said housings (13, 14)
9 Dispositif selon la revendication 8, caractérisé en ce que le second embout (9) comporte un filtre (8) formant un évent antibactérien9 Device according to claim 8, characterized in that the second nozzle (9) comprises a filter (8) forming an antibacterial vent
10 Dispositif selon la revendication 6, caractérisé en ce que l'un (14) au moins desdits logements (13, 14) comporte des moyens pour permettre un prémontage de l'un (16) desdits conteneurs (15, 16), ces moyens comprenant un élément d'arrêt (90) empêchant une activation accidentelle du système, un bourrelet antibactérien (91 ), un élément anti-retour (92) et un élément de blocage (93) empêchant le retrait du conteneur après l'activation10 Device according to claim 6, characterized in that at least one (14) of said housings (13, 14) comprises means for allowing a pre-assembly of one (16) of said containers (15, 16), these means comprising a stop element (90) preventing accidental activation of the system, an antibacterial bead (91), a non-return element (92) and a blocking element (93) preventing the withdrawal of the container after activation
11 Dispositif selon la revendication 6, caractérisé en ce que le conteneur contenant le composant liquide est une ampoule de verre (50) scellée à la flamme, et en ce que la zone de section rétrécie (13a) du logement (13) destiné à recevoir ce conteneur, comporte une butée (60) avec une rampe (61 ) destinées à briser un col de cette ampoule pour libérer le liquide qu'elle contient 12 Dispositif selon la revendication 1 , caractérise en ce que l'embout de transfert (19) est terminé par un cône Luer femelle et agencé pour permettre la connexion d'une seringue (24) ayant un embout Luer mâle11 Device according to claim 6, characterized in that the container containing the liquid component is a glass ampoule (50) sealed with flame, and in that the narrowed section area (13a) of the housing (13) intended to receive this container comprises a stop (60) with a ramp (61) intended to break a neck of this bulb to release the liquid which it contains 12 Device according to claim 1, characterized in that the transfer nozzle (19) is terminated by a female Luer cone and arranged to allow the connection of a syringe (24) having a male Luer nozzle
13 Dispositif selon la revendication 1 , caractérisé en ce que l'embout de transfert (19) est équipé d'une aiguille (30) agencée pour permettre la connexion avec une poche de perfusion (31 )13 Device according to claim 1, characterized in that the transfer nozzle (19) is equipped with a needle (30) arranged to allow connection with an infusion bag (31)
14 Dispositif selon la revendication 1 , caractérisé en ce que l'embout de transfert (19) contient une aiguille de seringue (42) agencée pour être connectée à une seringue (24) en vue de l'activation du système et du transfert de la solution reconstituée14 Device according to claim 1, characterized in that the transfer nozzle (19) contains a syringe needle (42) arranged to be connected to a syringe (24) for activation of the system and transfer of the reconstituted solution
15 Dispositif selon la revendication 11 , caractérisé en ce que le logement (13) comporte un filtre (6) antibactérien agencé pour filtrer le composant liquide avant son transfert à travers la canule (17) dans le flacon contenant la substance active15 Device according to claim 11, characterized in that the housing (13) comprises an antibacterial filter (6) arranged to filter the liquid component before its transfer through the cannula (17) into the bottle containing the active substance
16 Dispositif selon la revendication 1 , caractérisé en ce que ledit embout de transfert (19) est agencé pour contenir un réceptacle, constitué par une seringue (170), une cartouche vide (200) ou similaire16 Device according to claim 1, characterized in that said transfer nozzle (19) is arranged to contain a receptacle, constituted by a syringe (170), an empty cartridge (200) or the like
17 Dispositif selon la revendication 16, caractérisé en ce que l'embout de transfert (19) est amovible en vue d'une utilisation ultérieure avec ladite cartouche vide (200)17 Device according to claim 16, characterized in that the transfer nozzle (19) is removable for later use with said empty cartridge (200)
18 Dispositif selon la revendication 6, caractérisé en ce que au moins un desdits logements (13, 14) est agencé pour recevoir une ampoule (150, 160) scellée à la flamme 18 Device according to claim 6, characterized in that at least one of said housings (13, 14) is arranged to receive a bulb (150, 160) sealed with flame
PCT/CH1996/000429 1995-12-06 1996-12-04 Device for preparing a medicinal solution reconstituted from two components WO1997020536A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU76172/96A AU7617296A (en) 1995-12-06 1996-12-04 Device for preparing a medicinal solution reconstituted from two components

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH344295 1995-12-06
CH3442/95 1995-12-06

Publications (1)

Publication Number Publication Date
WO1997020536A1 true WO1997020536A1 (en) 1997-06-12

Family

ID=4256046

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CH1996/000429 WO1997020536A1 (en) 1995-12-06 1996-12-04 Device for preparing a medicinal solution reconstituted from two components

Country Status (2)

Country Link
AU (1) AU7617296A (en)
WO (1) WO1997020536A1 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6149623A (en) * 1996-01-11 2000-11-21 Duoject Medical Systems Inc. Delivery system for pharmaceuticals packed in pharmaceutical vials
WO2002062288A1 (en) * 2001-02-02 2002-08-15 Baxter International Inc. Reconstitution device and method of use
WO2002076374A1 (en) * 2001-03-27 2002-10-03 Eli Lilly And Company Kit including side firing syringe needle for preparing a drug in an injection pen cartridge
FR2828803A1 (en) * 2001-08-22 2003-02-28 Map France SAFETY PACKAGING FOR MEDICAL BOTTLE
EP1454650A1 (en) * 2003-03-06 2004-09-08 ZLB Behring GmbH Transfer device, in particular for medical fluids
WO2004108060A1 (en) * 2003-06-06 2004-12-16 Baxter International Inc. Reconstitution device and method of use
WO2006015332A1 (en) * 2004-07-29 2006-02-09 Boston Scientific Scimed, Inc. Vial adaptor
WO2006031500A2 (en) * 2004-09-10 2006-03-23 Becton, Dickinson And Company Reconstituting infusion device
EP2308452A1 (en) * 2009-10-12 2011-04-13 P2A Medical Perforating needle
US8197459B2 (en) 2003-03-05 2012-06-12 Aventis Behring Gmbh Self-sealing medical fluid transfer device
FR3011735A1 (en) * 2013-10-16 2015-04-17 Vygon DEVICE FOR INTERFACING A PERFORATING BOTTLE
US9345640B2 (en) 2009-04-14 2016-05-24 Yukon Medical, Llc Fluid transfer device
USD769444S1 (en) 2012-06-28 2016-10-18 Yukon Medical, Llc Adapter device
US10143625B2 (en) 2015-03-17 2018-12-04 Recon Therapeutics, Inc. Pharmaceutical reconstitution
WO2019015769A1 (en) * 2017-07-20 2019-01-24 Janssen Biotech, Inc. Drug mixing device
WO2019103160A1 (en) * 2017-11-27 2019-05-31 株式会社ヘリオス Adapter for cell drug vessel, multi-passage adapter for cell drug vessel, and cell drug transfer system and transfer method using same
CN110314087A (en) * 2018-03-30 2019-10-11 阿迪恩内制药和生物技术公司 For by infusion or injecting the aseptic flexible that fluid is medicinal or the dosage of nutriment the recombinates packaging applied to patient
US10729842B2 (en) 2012-09-24 2020-08-04 Enable Injections, Inc. Medical vial and injector assemblies and methods of use
WO2023213423A1 (en) * 2022-05-05 2023-11-09 Packsys Gmbh Applicator for an ampoule

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2584397A (en) * 1945-10-03 1952-02-05 Louis K Pitman Apparatus for transferring liquid from one container to another
US3857909A (en) * 1973-04-11 1974-12-31 Co Huggins J & Ass Gas nebulizing apparatus
EP0521460A1 (en) * 1991-07-04 1993-01-07 Axel von Brand Transfer and withdrawal spike
WO1994006690A1 (en) * 1992-09-21 1994-03-31 Habley Medical Technology Corporation Device and method for containing an ampule and transferring liquid within the ampule to a container
WO1994013344A1 (en) * 1992-12-15 1994-06-23 Gabriel Meyer Device for preparing a medicinal substance solution, suspension or emulsion
WO1996029113A1 (en) * 1995-03-20 1996-09-26 Medimop Medical Projects Ltd. Fluid control device

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2584397A (en) * 1945-10-03 1952-02-05 Louis K Pitman Apparatus for transferring liquid from one container to another
US3857909A (en) * 1973-04-11 1974-12-31 Co Huggins J & Ass Gas nebulizing apparatus
EP0521460A1 (en) * 1991-07-04 1993-01-07 Axel von Brand Transfer and withdrawal spike
WO1994006690A1 (en) * 1992-09-21 1994-03-31 Habley Medical Technology Corporation Device and method for containing an ampule and transferring liquid within the ampule to a container
WO1994013344A1 (en) * 1992-12-15 1994-06-23 Gabriel Meyer Device for preparing a medicinal substance solution, suspension or emulsion
WO1996029113A1 (en) * 1995-03-20 1996-09-26 Medimop Medical Projects Ltd. Fluid control device

Cited By (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638244B1 (en) 1996-01-11 2003-10-28 Duoject Medical Systems Inc. Delivery system for multi-component pharmaceuticals
US6149623A (en) * 1996-01-11 2000-11-21 Duoject Medical Systems Inc. Delivery system for pharmaceuticals packed in pharmaceutical vials
AU2002240070B2 (en) * 2001-02-02 2006-01-05 Baxter International Inc. Reconstitution device and method of use
WO2002062288A1 (en) * 2001-02-02 2002-08-15 Baxter International Inc. Reconstitution device and method of use
US6474375B2 (en) 2001-02-02 2002-11-05 Baxter International Inc. Reconstitution device and method of use
WO2002076374A1 (en) * 2001-03-27 2002-10-03 Eli Lilly And Company Kit including side firing syringe needle for preparing a drug in an injection pen cartridge
US7195623B2 (en) 2001-03-27 2007-03-27 Eli Lilly And Company Kit including side firing syringe needle for preparing a drug in an injection pen cartridge
AU2002248537B2 (en) * 2001-03-27 2006-07-13 Eli Lilly And Company Kit including side firing syringe needle for preparing a drug in an injection pen cartridge
FR2828803A1 (en) * 2001-08-22 2003-02-28 Map France SAFETY PACKAGING FOR MEDICAL BOTTLE
WO2003017916A1 (en) * 2001-08-22 2003-03-06 M.A.P. France Safety packaging for a bottle for medical use
US8197459B2 (en) 2003-03-05 2012-06-12 Aventis Behring Gmbh Self-sealing medical fluid transfer device
JP2004267776A (en) * 2003-03-06 2004-09-30 Aventis Behring Gmbh Transfer device for medical fluid
EP1454650A1 (en) * 2003-03-06 2004-09-08 ZLB Behring GmbH Transfer device, in particular for medical fluids
US7491197B2 (en) 2003-03-06 2009-02-17 Csl Behring Gmbh Fluid transfer device
WO2004108060A1 (en) * 2003-06-06 2004-12-16 Baxter International Inc. Reconstitution device and method of use
US6948522B2 (en) 2003-06-06 2005-09-27 Baxter International Inc. Reconstitution device and method of use
AU2004244978B2 (en) * 2003-06-06 2008-04-17 Takeda Pharmaceutical Company Limited Reconstitution device and method of use
US9884151B2 (en) 2003-07-22 2018-02-06 Becton, Dickinson And Company Reconstituting infusion device
US9044536B2 (en) 2003-07-22 2015-06-02 Becton, Dickinson And Company Reconstituting infusion device
US7615041B2 (en) 2004-07-29 2009-11-10 Boston Scientific Scimed, Inc. Vial adaptor
US8684992B2 (en) 2004-07-29 2014-04-01 Boston Scientific Scimed, Inc. Vial adaptor
WO2006015332A1 (en) * 2004-07-29 2006-02-09 Boston Scientific Scimed, Inc. Vial adaptor
US7981076B2 (en) 2004-09-10 2011-07-19 Becton, Dickinson And Company Reconstituting infusion device
WO2006031500A2 (en) * 2004-09-10 2006-03-23 Becton, Dickinson And Company Reconstituting infusion device
US8444597B2 (en) 2004-09-10 2013-05-21 Becton, Dickinson And Company Reconstituting infusion device
US8753310B2 (en) 2004-09-10 2014-06-17 Becton, Dickinson And Company Reconstituting infusion device
WO2006031500A3 (en) * 2004-09-10 2006-06-15 Becton Dickinson Co Reconstituting infusion device
US9345640B2 (en) 2009-04-14 2016-05-24 Yukon Medical, Llc Fluid transfer device
EP2308452A1 (en) * 2009-10-12 2011-04-13 P2A Medical Perforating needle
FR2951075A1 (en) * 2009-10-12 2011-04-15 P2A Medical PERFORATING NEEDLE
USD769444S1 (en) 2012-06-28 2016-10-18 Yukon Medical, Llc Adapter device
US10729842B2 (en) 2012-09-24 2020-08-04 Enable Injections, Inc. Medical vial and injector assemblies and methods of use
US10500134B2 (en) 2013-10-16 2019-12-10 Vygon Device for interfacing a vial to be perforated
WO2015055751A1 (en) * 2013-10-16 2015-04-23 Vygon Device for interfacing a flask to be perforated
FR3011735A1 (en) * 2013-10-16 2015-04-17 Vygon DEVICE FOR INTERFACING A PERFORATING BOTTLE
CN105792792A (en) * 2013-10-16 2016-07-20 维格恩公司 Device for interfacing a flask to be perforated
US10143625B2 (en) 2015-03-17 2018-12-04 Recon Therapeutics, Inc. Pharmaceutical reconstitution
CN111107828A (en) * 2017-07-20 2020-05-05 詹森生物科技公司 Medicine mixing device
WO2019015769A1 (en) * 2017-07-20 2019-01-24 Janssen Biotech, Inc. Drug mixing device
WO2019103160A1 (en) * 2017-11-27 2019-05-31 株式会社ヘリオス Adapter for cell drug vessel, multi-passage adapter for cell drug vessel, and cell drug transfer system and transfer method using same
JPWO2019103160A1 (en) * 2017-11-27 2020-12-17 株式会社ヘリオス Adapter for cell drug container, multiple adapter for cell drug container, and cell drug transfer system and transfer method using this
JP7271436B2 (en) 2017-11-27 2023-05-11 株式会社ヘリオス Cellular medicine transfer method
US11752069B2 (en) 2017-11-27 2023-09-12 Healios K. K. Method for transferring cellular medicine using a cellular medicine transfer system
CN110314087A (en) * 2018-03-30 2019-10-11 阿迪恩内制药和生物技术公司 For by infusion or injecting the aseptic flexible that fluid is medicinal or the dosage of nutriment the recombinates packaging applied to patient
WO2023213423A1 (en) * 2022-05-05 2023-11-09 Packsys Gmbh Applicator for an ampoule
WO2023213399A1 (en) * 2022-05-05 2023-11-09 Packsys Gmbh Applicator for an ampoule

Also Published As

Publication number Publication date
AU7617296A (en) 1997-06-27

Similar Documents

Publication Publication Date Title
EP0403626B1 (en) Storage and transfer bottle designed for storing two components of a medicamental substance
EP0406374B1 (en) Storage and transfer bottle designed for storing a component of a medicamental substance
WO1997020536A1 (en) Device for preparing a medicinal solution reconstituted from two components
EP0453555B1 (en) Storage bottle containing a constituent of a medicinal solution
EP0684846B1 (en) Prefilled syringe for storing and dispensing a sterile liquid drug
EP0717611B1 (en) Syringe device for mixing two compounds
EP0625917B1 (en) Device for preparing a medicinal substance solution, suspension or emulsion
CA2147414C (en) Process for filling a sealed recipient in aseptic conditions
EP1589926B2 (en) Device and method for the extemporaneous preparation of an individual quantity of sterile fluid
EP1239808A1 (en) Device for connection between a vessel and a container and ready-to-use assembly comprising same
FR2717086A1 (en) Syringe system for mixing two compounds
WO1999036029A1 (en) Sealed confinement device for connecting a container and means for delivering a substance
WO2002053086A1 (en) Ampule for packaging and transferring a liquid or a powder for medical use
WO1995032015A1 (en) Device for the preparation of a solution, a suspension or an emulsion of a medicinal substance
EP1949883B1 (en) Method and set for transferring a fluid between two containers
EP1034772B1 (en) Device for transfering a substance contained in a vial to a pouch containing a solute
FR2767514A1 (en) Container for mixing two part compounds just prior to injection by syringe
EP3348249B1 (en) Device for extemporaneous preparation of an amount of sterile fluid
CA3006648C (en) Device for connecting a vessel and a container and connection assembly including such a device
FR2708469A1 (en) Syringe device for mixing two compositions
FR2714294A1 (en) Syringe system for mixing two compounds
FR2715311A1 (en) Syringe system for mixing two compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97520835

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase